FBS, A JOURNAL AND VIRTUAL LIBRARY

FRONTIERS IN BIOSCIENCE;
AUTHOR LIST: 2002

Firs t Name	Last Name	Address	Email	Tel	Fax	Title 2002	Citation	PubMed
Michael	Cho	University of Illinois, Chicago, IL 60607	mcho@uic.edu	312-996-5921	312-413-9424	Control of calcium entry in human fibroblasts by frequency-dependent electrical stimulation	[Frontiers in Bioscience 7, a1-8, January 1, 2002]	11779692
Joan	Marler	Wellesley College, Wellesley, MA 02481				Control of calcium entry in human fibroblasts by frequency-dependent electrical stimulation	[Frontiers in Bioscience 7, a1-8, January 1, 2002]	11779692
Hemant	Thatte	Harvard Medical School and Boston VA HealthCare System, West Roxbury, MA 02132				Control of calcium entry in human fibroblasts by frequency-dependent electrical stimulation	[Frontiers in Bioscience 7, a1-8, January 1, 2002]	11779692
David	Golan	Harvard Medical School; Hematology Division, Brigham and Women's Hospital, Boston, MA 02115				Control of calcium entry in human fibroblasts by frequency-dependent electrical stimulation	[Frontiers in Bioscience 7, a1-8, January 1, 2002]	11779692
Wu-Nan	Kuo	University of Illinois, Chicago, IL 60607	kuow@cookman.edu	386-481-2662	386-481-2697	Protein denitration/modification by Escherichia Coli nitrate reductase and mammalian cytochrome P-450 reductase	[Frontiers in Bioscience 7, a9-14, February 1, 2002]	11815290
Joseph	Kocis	Bethune-Cookman College, Daytona Beach,Florida				Protein denitration/modification by Escherichia Coli nitrate reductase and mammalian cytochrome P-450 reductase	[Frontiers in Bioscience 7, a9-14, February 1, 2002]	11815290
Jenny	Webb	Bethune-Cookman College, Daytona Beach,Florida				Protein denitration/modification by Escherichia Coli nitrate reductase and mammalian cytochrome P-450 reductase	[Frontiers in Bioscience 7, a9-14, February 1, 2002]	11815290
Shi-Fa	Ding	University of Toronto, Toronto, Ontario M5S 3E2, Canada				A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAS, and trans-dominant negative mutant gag and env proteins	[Frontiers in Bioscience 7, a15-28, February 1, 2002]	11815282
Rocco	Lombardi	University of Toronto, Toronto, Ontario M5S 3E2, Canada				A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAS, and trans-dominant negative mutant gag and env proteins	[Frontiers in Bioscience 7, a15-28, February 1, 2002]	11815282
Reza	Nazari	University of Toronto, Toronto, Ontario M5S 3E2, Canada				A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAS, and trans-dominant negative mutant gag and env proteins	[Frontiers in Bioscience 7, a15-28, February 1, 2002]	11815282
Sadhna	Joshi	University of Toronto, Toronto, Ontario M5S 3E2, Canada	sadhnajoshi@yahoo.com	416-638-1459	416-978-2499	A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAS, and trans-dominant negative mutant gag and env proteins	[Frontiers in Bioscience 7, a15-28, February 1, 2002]	11815282
Ali Ramezani		University of Toronto, Toronto, Ontario M5S 3E2, Canada				Development and testing of retroviral vectors expressing multimeric hammerhead ribozymes targeted against all major clades of HIV-1	[Frontiers in Bioscience 7, a29-36, February 1, 2002]	11815297
Xue Zhong Ma		University of Toronto, Toronto, Ontario M5S 3E2, Canada				Development and testing of retroviral vectors expressing multimeric hammerhead ribozymes targeted against all major clades of HIV-1	[Frontiers in Bioscience 7, a29-36, February 1, 2002]	11815297
Sadhna	Joshi	University of Toronto, Toronto, Ontario M5S 3E2, Canada	sadhnajoshi@yahoo.com	416-638-1459	416-978-2499	Development and testing of retroviral vectors expressing multimeric hammerhead ribozymes targeted against all major clades of HIV-1	[Frontiers in Bioscience 7, a29-36, February 1, 2002]	11815297
Charles	Denko,	Case Western Reserve University School of Medicine				Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH)	[Frontiers in Bioscience 7, a37-43, April 1, 2002]	11897552
Betty	Boja	Case Western Reserve University School of Medicine				Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH)	[Frontiers in Bioscience 7, a37-43, April 1, 2002]	11897552
Charles J.	Malemud	Case Western Reserve University School of Medicine	cjm4@po.cwru.edu	216-368-1332	216-368-1372	Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH)	[Frontiers in Bioscience 7, a37-43, April 1, 2002]	11897552
T. Tabira	Tabira	National Institute for Longevity Sciences, Obu, Aichi 474-8522, Japan	tabira@nils.go.jp	81 562-45-0184	81 562-45-0183	Significance of intracellular Ab42 accumulation in alzheimer's disease	[Frontiers in Bioscience 7, a44-49, April 1, 2002]	11897569
D. H.	Chui	Riken Brain Science Institute, Wako, Saitama 351-0198, Japan				Significance of intracellular Ab42 accumulation in alzheimer's disease	[Frontiers in Bioscience 7, a44-49, April 1, 2002]	11897569
S.	Kuroda	Okayama University Medical School, Okayama 700-8558, Japan				Significance of intracellular Ab42 accumulation in alzheimer's disease	[Frontiers in Bioscience 7, a44-49, April 1, 2002]	11897569
Joseph	Buxbaum	Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029	buxbaj01@doc.mssm.edu	212-828-4221	212-659-8862	Pharmacological concentrations of the HMG-COA reductase inhibitor lovastatin decrease the formation of the Alzheimer b-amyloid peptide in vitro and in patients	[Frontiers in Bioscience 7, a50-59, April 1, 2002]	11900994
Edward	Cullen	Andrx Laboratories, a division of Andrx Corporation, 401 Hackensack Avenue, Hackensack, NJ 07601				Pharmacological concentrations of the HMG-COA reductase inhibitor lovastatin decrease the formation of the Alzheimer b-amyloid peptide in vitro and in patients	[Frontiers in Bioscience 7, a50-59, April 1, 2002]	11900994
Lawrence	Friedhoff	Andrx Laboratories, a division of Andrx Corporation, 401 Hackensack Avenue, Hackensack, NJ 07601				Pharmacological concentrations of the HMG-COA reductase inhibitor lovastatin decrease the formation of the Alzheimer b-amyloid peptide in vitro and in patients	[Frontiers in Bioscience 7, a50-59, April 1, 2002]	11900994
Neena	Singh	Case Western Reserve University, 2085, Adelbert Road, Cleveland, Ohio	nxs2@po.cwru.edu	216-368-2546	216-368-2617	Prion peptide 106-126 as a model for prion replication and neurotoxicity	[Frontiers in Bioscience 7, a60-71, April 1, 2002]	11897566
Yaping	Gu	Case Western Reserve University, 2085, Adelbert Road, Cleveland, Ohio				Prion peptide 106-126 as a model for prion replication and neurotoxicity	[Frontiers in Bioscience 7, a60-71, April 1, 2002]	11897566
Sharmila	Bose	Case Western Reserve University, 2085, Adelbert Road, Cleveland, Ohio				Prion peptide 106-126 as a model for prion replication and neurotoxicity	[Frontiers in Bioscience 7, a60-71, April 1, 2002]	11897566
Sudheera	Kalepu	Case Western Reserve University, 2085, Adelbert Road, Cleveland, Ohio				Prion peptide 106-126 as a model for prion replication and neurotoxicity	[Frontiers in Bioscience 7, a60-71, April 1, 2002]	11897566
Ravi	Mishra	Case Western Reserve University, 2085, Adelbert Road, Cleveland, Ohio				Prion peptide 106-126 as a model for prion replication and neurotoxicity	[Frontiers in Bioscience 7, a60-71, April 1, 2002]	11897566
Susamma	Verghese	Case Western Reserve University, 2085, Adelbert Road, Cleveland, Ohio				Prion peptide 106-126 as a model for prion replication and neurotoxicity	[Frontiers in Bioscience 7, a60-71, April 1, 2002]	11897566
Isaac	Pessah	University of California, Davis, CA 95616	inpessah@ucdavis.edu	530-752-4698	530-752-6696	Redox sensing properties of the Ryanodine receptor complex	[Frontiers in Bioscience 7, a72-79, May, 2002]	11991848
Kyung	Kim	University of California, Davis, CA 95616				Redox sensing properties of the Ryanodine receptor complex	[Frontiers in Bioscience 7, a72-79, May, 2002]	11991848
Wei	Feng	University of California, Davis, CA 95616				Redox sensing properties of the Ryanodine receptor complex	[Frontiers in Bioscience 7, a72-79, May, 2002]	11991848
Gyongyi	Szabo	Massachusetts Medical School, LRB 215, 364 Plantation Street, Worcester, MA	gyongyi.szabo@umassmed.edu	508-856-4770	508-856-5275	Redox sensing properties of the Ryanodine receptor complex	[Frontiers in Bioscience 7, a72-79, May, 2002]	11991856
Pranoti	Mandrekar	University of Massachusetts Medical School, LRB 213, 364 Plantation Street, Worcester, MA				Redox sensing properties of the Ryanodine receptor complex	[Frontiers in Bioscience 7, a72-79, May, 2002]	11991856
Hongzhe	Li	University of California, Davis, CA 95616, USA	hli@dna.ucdavis.edu	530-754-6015	530- 754-9234	Ethanol-mediated regulation of transcription factors in immunocompetent cells	[Frontiers in Bioscience 7, a80-89, May 1, 2002]	11991842
Yihui	Luan	University of California, Davis, CA 95616, USA				Ethanol-mediated regulation of transcription factors in immunocompetent cells	[Frontiers in Bioscience 7, a80-89, May 1, 2002]	11991842
Fangxin	Hong	University of California, Davis, CA 95616, USA				Ethanol-mediated regulation of transcription factors in immunocompetent cells	[Frontiers in Bioscience 7, a80-89, May 1, 2002]	11991842
Yueju	Li	University of California, Davis, CA 95616, USA				Ethanol-mediated regulation of transcription factors in immunocompetent cells	[Frontiers in Bioscience 7, a80-89, May 1, 2002]	11991842
Judy A.	Spitzer	Louisiana State University Health Sciences Center, New Orleans, LA 70112	jspitz1@lsumc.edu	504-568-6158	504-568-6175	Ethanol and LPS modulate NF-KappaB activation, inducible no synthase and Cox-2 gene expression in rat liver cells in vivo	[Frontiers in Bioscience 7, a99-108, May 1, 2002]	11994208
Mingquan	Zheng	University of California, Davis, CA 95616, USA				Ethanol and LPS modulate NF-KappaB activation, inducible no synthase and Cox-2 gene expression in rat liver cells in vivo	[Frontiers in Bioscience 7, a99-108, May 1, 2002]	11994208
Jay	Kolls	University of California, Davis, CA 95616, USA				Ethanol and LPS modulate NF-KappaB activation, inducible no synthase and Cox-2 gene expression in rat liver cells in vivo	[Frontiers in Bioscience 7, a99-108, May 1, 2002]	11994208
Curtis	Stouwe	University of California, Davis, CA 95616, USA				Ethanol and LPS modulate NF-KappaB activation, inducible no synthase and Cox-2 gene expression in rat liver cells in vivo	[Frontiers in Bioscience 7, a99-108, May 1, 2002]	11994208
John	Spitzer	University of California, Davis, CA 95616, USA				Ethanol and LPS modulate NF-KappaB activation, inducible no synthase and Cox-2 gene expression in rat liver cells in vivo	[Frontiers in Bioscience 7, a99-108, May 1, 2002]	11994208
Gianfranco	Peluso	CNR, Naples, Italy and Department of Experimental Oncology, National Cancer Institute, Naples, Italy	peluso@dafne.ibpe.na.cnr.it	+39-081-6132277	+39-081-6132282	Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients	[Frontiers in Bioscience 7, a109-116, May 1, 2002]	11991847
Orsolina	Petillo	CNR, Naples, Italy and Department of Experimental Oncology, National Cancer Institute, Naples, Italy				Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients	[Frontiers in Bioscience 7, a109-116, May 1, 2002]	11991847
Sabrina	Margarucci	Catholic University, School of Medicine, Rome, Italy				Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients	[Frontiers in Bioscience 7, a109-116, May 1, 2002]	11991847
Gertrude	Mingrone	Catholic University, School of Medicine, Rome, Italy				Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients	[Frontiers in Bioscience 7, a109-116, May 1, 2002]	11991847
Aldo	Greco	Catholic University, School of Medicine, Rome, Italy				Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients	[Frontiers in Bioscience 7, a109-116, May 1, 2002]	11991847
Cesare	Indiveri	University of Bari, Bari, Italy				Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients	[Frontiers in Bioscience 7, a109-116, May 1, 2002]	11991847
Ferdinando	Palmieri	University of Bari, Bari, Italy				Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients	[Frontiers in Bioscience 7, a109-116, May 1, 2002]	11991847
Mariarosa	Melone	Department of Neurological Sciences, Second University of Naples, Italy				Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients	[Frontiers in Bioscience 7, a109-116, May 1, 2002]	11991847
Emilia	Reda	Second University of Naples; Sigma Tau SpA, Rome, Italy				Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients	[Frontiers in Bioscience 7, a109-116, May 1, 2002]	11991847
Menotti	Calvani	Second University of Naples; Sigma Tau SpA, Rome, Italy				Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients	[Frontiers in Bioscience 7, a109-116, May 1, 2002]	11991847
Abraham	Bautista	Louisiana State University Health Sciences Center, New Orleans, Louisiana	abauti123@cs.com	301-480 2241	301-435-1506	Chronic alcohol intoxication primes kupffer cells and endothelial cells for enhanced CC-chemokine production and concomitantly suppresses phagocytosis and chemotaxis	[Frontiers in Bioscience 7, a117-125, June 1, 2002]	12045006
Lei	Qian	Indiana University - Purdue University Indianapolis, Indianapolis, IN				Systems analysis of matrix metalloproteinase mRNA expression in skeletal tissues	[Frontiers in Bioscience 7, a126-134, June 1, 2002]	12045007
Yunlong	Liu	Indiana University - Purdue University Indianapolis, Indianapolis, IN				Systems analysis of matrix metalloproteinase mRNA expression in skeletal tissues	[Frontiers in Bioscience 7, a126-134, June 1, 2002]	12045007
Hui	Sun	Indiana University - Purdue University Indianapolis, Indianapolis, IN				Systems analysis of matrix metalloproteinase mRNA expression in skeletal tissues	[Frontiers in Bioscience 7, a126-134, June 1, 2002]	12045007
Hiroki	Yokota	Indiana University - Purdue University Indianapolis, Indianapolis, IN	hyokota@iupui.edu	317-278-2040	317-274-2448	Systems analysis of matrix metalloproteinase mRNA expression in skeletal tissues	[Frontiers in Bioscience 7, a126-134, June 1, 2002]	12045007
Omar	Latif	Stanford University School of Medicine, Stanford, CA 94305				Alcohol-mediated polarization of type 1 and type 2 immune responses	[Frontiers in Bioscience 7, a135-147, August 1, 2002]	12133821
Jeffrey	Peterson	CuraGen, Inc., Branford, CT 06405				Alcohol-mediated polarization of type 1 and type 2 immune responses	[Frontiers in Bioscience 7, a135-147, August 1, 2002]	12133821
Carl	Waltenbaugh	Northwestern University Medical School, Chicago, IL 60611	waltenbaugh@northwestern.edu	312-503-8459	312-503-8459	Alcohol-mediated polarization of type 1 and type 2 immune responses	[Frontiers in Bioscience 7, a135-147, August 1, 2002]	12133821
Sandra	Goettsch	Max-Planck Institute for Molecular Physiology, Research Group Molecular and Structural Biophysics, Otto-Hahn-Str.11, D-44227 Dortmund, Germany				Structural attributes in the conjugation of Ubiquitin, SUMO and RUB to protein substrates	[Frontiers in Bioscience 7, a148-162, August 1, 2002]	12133807
Peter	Bayer	Max-Planck Institute for Molecular Physiology, Research Group Molecular and Structural Biophysics, Otto-Hahn-Str.11, D-44227 Dortmund, Germany	peter.bayer@mpi-dortmund.mpg.de	++49-231-133-2699	++49-231-133-2222	Structural attributes in the conjugation of Ubiquitin, SUMO and RUB to protein substrates	[Frontiers in Bioscience 7, a148-162, August 1, 2002]	12133807
Joseph F.	Clark	The Neuroscience Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio	joseph.clark@uc.edu	513-558-7009	513-558-7085	Isoforms of apolipoprotein E can modulate TPA-induced clot lysis in vitro	[Frontiers in Bioscience 7, a163-168, August 1, 2002]	12133811
Daniel	Huri	The Neuroscience Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio				Isoforms of apolipoprotein E can modulate TPA-induced clot lysis in vitro	[Frontiers in Bioscience 7, a163-168, August 1, 2002]	12133811
Janice	Carrozzella	The Neuroscience Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio				Isoforms of apolipoprotein E can modulate TPA-induced clot lysis in vitro	[Frontiers in Bioscience 7, a163-168, August 1, 2002]	12133811
Edward	Jauch	The Neuroscience Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio				Isoforms of apolipoprotein E can modulate TPA-induced clot lysis in vitro	[Frontiers in Bioscience 7, a163-168, August 1, 2002]	12133811
Pritesh	Mehta	The Neuroscience Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio				Isoforms of apolipoprotein E can modulate TPA-induced clot lysis in vitro	[Frontiers in Bioscience 7, a163-168, August 1, 2002]	12133811
Daniel	Heaton	The Neuroscience Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio				Isoforms of apolipoprotein E can modulate TPA-induced clot lysis in vitro	[Frontiers in Bioscience 7, a163-168, August 1, 2002]	12133811
Susan	Biehle	The Neuroscience Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio				Isoforms of apolipoprotein E can modulate TPA-induced clot lysis in vitro	[Frontiers in Bioscience 7, a163-168, August 1, 2002]	12133811
Joseph	Broderick	The Neuroscience Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio				Isoforms of apolipoprotein E can modulate TPA-induced clot lysis in vitro	[Frontiers in Bioscience 7, a163-168, August 1, 2002]	12133811
Hui	Sun	Indiana University - Purdue University Indianapolis, Indianapolis, Indiana 46202				Promoter competition assay for analyzing gene regulation in joint tissue engineering	[Frontiers in Bioscience 7, a169-174, August 1, 2002]	12133815
George	Malacinski	Indiana University, Bloomington, Indiana 47405				Promoter competition assay for analyzing gene regulation in joint tissue engineering	[Frontiers in Bioscience 7, a169-174, August 1, 2002]	12133815
Hiroki	Yokota	Indiana University - Purdue University Indianapolis, Indianapolis, Indiana 46202	hyokota@iupui.edu	317-278-2040	317-274-2448	Promoter competition assay for analyzing gene regulation in joint tissue engineering	[Frontiers in Bioscience 7, a169-174, August 1, 2002]	12133815
Joseph	Kocis	Bethune-Cookman College, Daytona Beach, Florida 32114				Regulation of catalase: inhibition by peroxynitrite and reactivation by reduced glutathione and glutathione S-transferase	[Frontiers in Bioscience 7, a175-180, October 1, 2002]	12165482
Wu-Nan	Kuo	Bethune-Cookman College, Daytona Beach, Florida 32114	kuow@hotmail.com	386-481-2657	386-481-2697	Regulation of catalase: inhibition by peroxynitrite and reactivation by reduced glutathione and glutathione S-transferase	[Frontiers in Bioscience 7, a175-180, October 1, 2002]	12165482
Yang	Liu	Bethune-Cookman College, Daytona Beach, Florida 32114				Regulation of catalase: inhibition by peroxynitrite and reactivation by reduced glutathione and glutathione S-transferase	[Frontiers in Bioscience 7, a175-180, October 1, 2002]	12165482
Luvina	Guruvadoo	Bethune-Cookman College, Daytona Beach, Florida 32114				Regulation of catalase: inhibition by peroxynitrite and reactivation by reduced glutathione and glutathione S-transferase	[Frontiers in Bioscience 7, a175-180, October 1, 2002]	12165482
Joseph	Langat	Bethune-Cookman College, Daytona Beach, Florida 32114				Regulation of catalase: inhibition by peroxynitrite and reactivation by reduced glutathione and glutathione S-transferase	[Frontiers in Bioscience 7, a175-180, October 1, 2002]	12165482
Ahmed	Shafik	Cairo University, Cairo, Egypt	ashafik@ahmedshafik.org	+20-2-749 8851	+20-2-749 8851	Electrophysiologic identification of the location of the colonic pacemakers. a human study	[Frontiers in Bioscience 7, b1-5, February 1, 2002]	11815299
Olfat	El-Sibai	Menoufia University, Shebin El-Kom, Cairo, Egypt				Electrophysiologic identification of the location of the colonic pacemakers. a human study	[Frontiers in Bioscience 7, b1-5, February 1, 2002]	11815299
Ali	Shafik	Cairo University, Cairo, Egypt				Electrophysiologic identification of the location of the colonic pacemakers. a human study	[Frontiers in Bioscience 7, b1-5, February 1, 2002]	11815299
Ahmed	Shafik	Cairo University, Cairo, Egypt	ashafik@ahmedshafik.org	+20-2-749 8851	+20-2-749 8851	The motor efficacy of the artificial colonic pacemaker in colonic inertia patients	[Frontiers in Bioscience 7, b6-13, June 1, 2002]	12045022
Olfat	El-Sibai	Menoufia University, Shebin El-Kom, Cairo, Egypt				The motor efficacy of the artificial colonic pacemaker in colonic inertia patients	[Frontiers in Bioscience 7, b6-13, June 1, 2002]	12045022
Ali	Shafik	Cairo University, Cairo, Egypt				The motor efficacy of the artificial colonic pacemaker in colonic inertia patients	[Frontiers in Bioscience 7, b6-13, June 1, 2002]	12045022
Ismail	Ahmed	Cairo University, Cairo, Egypt				The motor efficacy of the artificial colonic pacemaker in colonic inertia patients	[Frontiers in Bioscience 7, b6-13, June 1, 2002]	12045022
John L.	Tonkinson	Schleicher & Schuell BioScience, Inc., 10 Optical Ave, Keene, NH, 03431	john_tonkinson@s-and-s.com	603-357-3627	603-352-3810 x3378	Nitrocellulose: a tried and true polymer finds utility as a post-genomic substrate	[Frontiers in Bioscience 7, c1-12, January 1, 2002]	11779718
Brett	Stillman	Schleicher & Schuell BioScience, Inc., 10 Optical Ave, Keene, NH, 03431				Nitrocellulose: a tried and true polymer finds utility as a post-genomic substrate	[Frontiers in Bioscience 7, c1-12, January 1, 2002]	11779718
Dieter	Stoll	University of Tuebingen, Markwiesenstr. 55, 72770 Reutlingen, Germany	joos@nmi.de	+49 7121 51530 16	+49 7121 51530 844	Protein microarray technology	[Frontiers in Bioscience 7, c13-32, January 1, 2002]	11779717
Markus	Templin	University of Tuebingen, Markwiesenstr. 55, 72770 Reutlingen, Germany				Protein microarray technology	[Frontiers in Bioscience 7, c13-32, January 1, 2002]	11779717
Monika	Schrenk	University of Tuebingen, Markwiesenstr. 55, 72770 Reutlingen, Germany				Protein microarray technology	[Frontiers in Bioscience 7, c13-32, January 1, 2002]	11779717
Petra	Traub	University of Tuebingen, Markwiesenstr. 55, 72770 Reutlingen, Germany				Protein microarray technology	[Frontiers in Bioscience 7, c13-32, January 1, 2002]	11779717
Christian	Vöhringer	University of Tuebingen, Markwiesenstr. 55, 72770 Reutlingen, Germany				Protein microarray technology	[Frontiers in Bioscience 7, c13-32, January 1, 2002]	11779717
Thomas	Joos	University of Tuebingen, Markwiesenstr. 55, 72770 Reutlingen, Germany	joos@nmi.de	+49 7121 51530	+49 7121 51530 844	Protein microarray technology	[Frontiers in Bioscience 7, c13-32, January 1, 2002]	11779717
Howard	Meyerson	Case Western Reserve University, Cleveland, Ohio	hjm2@po.cwru.edu	216-844-5601	216-844-1848	Applications of enzymatic amplification staining in immunophenotyping hematopoietic cells	[Frontiers in Bioscience 7, c33-43, April 1, 2002]	11897560
David	Kaplan	Case Western Reserve University, Cleveland, Ohio	hjm2@po.cwru.edu	216-844-5601	216-844-1848	Protein microarray technology	[Frontiers in Bioscience 7, c13-32, January 1, 2002]	11897560
Richard	Bankert,	State University of New York at Buffalo, Buffalo, NY, U.S.A.	rbankert@buffalo.edu	716-829-2662	716-829-2701	SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions	[Frontiers in Bioscience 7, c44-62 May 1, 2002]	11915860
Stephen	Hess	State University of New York at Buffalo, Buffalo, NY, U.S.A.	sdhess@hotmail.com	716-829-2662	716-829-3734	SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions	[Frontiers in Bioscience 7, c44-62 May 1, 2002]	11915860
Nejat	Egilmez	State University of New York at Buffalo, Buffalo, NY, U.S.A.	negilmez@buffalo.edu	716-829-2662	716-829-3734	SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions	[Frontiers in Bioscience 7, c44-62 May 1, 2002]	11915860
Heping	Zhang	Public Health , Yale University School of Medicine, New Haven, CT	heping.zhang@yale.edu	203-785-6912	203-785-2838	Tree-based analysis of microarray data for classifying breast cancer	[Frontiers in Bioscience 7, c63-67, May 1, 2002]	11991861
Chang-Yung	Yu	Public Health , Yale University School of Medicine, New Haven, CT				Tree-based analysis of microarray data for classifying breast cancer	[Frontiers in Bioscience 7, c63-67, May 1, 2002]	11991861
Kotoko	Nakata	National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo, 1508-8501, Japan	nakata@nihs.go	81-3-5717-7180	81-3-3700-9572	Theoretical approach to endocrine disruptors	[Frontiers in Bioscience 7, c68-73, July 1, 2002]	12086919
Stephen	Hunter	Emory University School of Medicine, Atlanta, Georgia	Stephen_Hunter@Emory.org	404-712-4754	404-712-4278	Expression microarray analysis of brain tumors: what have we learned so far	[Frontiers in Bioscience 7, c74-82, August 1, 2002]	12133823
Carlos	Moreno	Emory University School of Medicine, Atlanta, Georgia				Expression microarray analysis of brain tumors: what have we learned so far	[Frontiers in Bioscience 7, c74-82, August 1, 2002]	12133823
Jennifer	Clark	ALS Therapy Development Foundation, 44 Glen Avenue, Newton MA 02459	jclark@als-tdf.org	617-796-9652	617-796-8826	Novel trends in orphan market drug discovery: amyotrophic lateral sclerosis as a case study	[Frontiers in Bioscience 7, c83-96, August 1, 2002]	12133810
Avis	Brennan	ALS Therapy Development Foundation, 44 Glen Avenue, Newton MA 02459				Novel trends in orphan market drug discovery: amyotrophic lateral sclerosis as a case study	[Frontiers in Bioscience 7, c83-96, August 1, 2002]	12133810
Tennore	Ramesh	ALS Therapy Development Foundation, 44 Glen Avenue, Newton MA 02459				Novel trends in orphan market drug discovery: amyotrophic lateral sclerosis as a case study	[Frontiers in Bioscience 7, c83-96, August 1, 2002]	12133810
Allen	Heywood	ALS Therapy Development Foundation, 44 Glen Avenue, Newton MA 02459				Novel trends in orphan market drug discovery: amyotrophic lateral sclerosis as a case study	[Frontiers in Bioscience 7, c83-96, August 1, 2002]	12133810
Heinz-Jürgen	Steinhoff	Fachbereich Physik, Universität Osnabrück, Barbarastrasse 7, D-49069 Osnabrück, Germany	hsteinho@uni-osnabrueck.de	+49-541-969-2656	+49 541-969-2664	Methods for study of protein dynamics and protein-protein interaction in protein-ubiquitination by electron paramagnetic resonance spectroscopy	[Frontiers in Bioscience 7, c97-110, September 1, 2002]	12161339
Mustapha	Samrakandi	University of Nebraska, Lincoln, 203 VBS, Fair and East Campus Loop, Lincoln, NE 68583				Entry into host cells by Legionella	[Frontiers in Bioscience 7, d1-11, January 1, 2002]	11779713
Dennis	Ridenour	University of Nebraska, Lincoln, 203 VBS, Fair and East Campus Loop, Lincoln, NE 68583				Entry into host cells by Legionella	[Frontiers in Bioscience 7, d1-11, January 1, 2002]	11779713
Ling	Yan	University of Nebraska, Lincoln, 203 VBS, Fair and East Campus Loop, Lincoln, NE 68583				Entry into host cells by Legionella	[Frontiers in Bioscience 7, d1-11, January 1, 2002]	11779713
Jeffrey D.	Cirillo	University of Nebraska, Lincoln, 203 VBS, Fair and East Campus Loop, Lincoln, NE 68583	jcirillo1@unl.edu	402-472-9690	402- 472-8587	Entry into host cells by Legionella	[Frontiers in Bioscience 7, d1-11, January 1, 2002]	11779713
Lori L	Isom	The University of Michigan, Ann Arbor, MI	Lisom@umich.edu	734-763-4450	734-936-3050	The role of sodium channels in cell adhesion	[Frontiers in Bioscience 7, d12-23, January 1, 2002]	11779698
Xosé	Bustelo	Instituto de Biología Molecular y Celular del Cáncer. University of Salamanca-CSIC. 37007 Salamanca, Spain	xbustelo@usal.es	34-923-294743	34-923-294802	Regulation of Vav proteins by intramolecular events	[Frontiers in Bioscience 7, d24-30, January 1, 2002]	11779690
Jodi M.	Smith	University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030-3301				ABL: mechanisms of regulation and activation	[Frontiers in Bioscience 7, d31-42, January 1, 2002]	11779715
Bruce J.	Mayer	Harvard Medical School, Boston, MA 02115 USA	bmayer@neuron.uchc.edu	860-679-8345	860-679-1836	ABL: mechanisms of regulation and activation	[Frontiers in Bioscience 7, d31-42, January 1, 2002]	11779715
Masoud H. Manjili		Roswell Park Cancer Institute, Buffalo, New York 14263				Immunotherapy of cancer using heat shock proteins	[Frontiers in Bioscience 7, d43-52, January 1, 2002]	11779704
Xiang-Yang Wang		Roswell Park Cancer Institute, Buffalo, New York 14263				Immunotherapy of cancer using heat shock proteins	[Frontiers in Bioscience 7, d43-52, January 1, 2002]	11779704
Juneui Park		Roswell Park Cancer Institute, Buffalo, New York 14263				Immunotherapy of cancer using heat shock proteins	[Frontiers in Bioscience 7, d43-52, January 1, 2002]	11779704
John G. Facciponte		Roswell Park Cancer Institute, Buffalo, New York 14263				Immunotherapy of cancer using heat shock proteins	[Frontiers in Bioscience 7, d43-52, January 1, 2002]	11779704
Elizabeth A. Repasky		Roswell Park Cancer Institute, Buffalo, New York 14263				Immunotherapy of cancer using heat shock proteins	[Frontiers in Bioscience 7, d43-52, January 1, 2002]	11779704
John R. Subjeck		Roswell Park Cancer Institute, Buffalo, New York 14263	john.subjeck@roswellpark.org	716-845-8899	716-845-3147	Immunotherapy of cancer using heat shock proteins	[Frontiers in Bioscience 7, d43-52, January 1, 2002]	11779704
Ján	Lehotsky	Malá Hora 4, SK-03601 Martin, Slovakia	Jan.Lehotsky@jfmed.uniba.sk	421-43-4136332	421-43-4131565	The role of plasma membrane CA²⁺ Pumps (PMCAs) in pathologies of mammalian cells	[Frontiers in Bioscience 7, d53-84, January 1, 2002]	11779702
Peter	Kaplán	Malá Hora 4, SK-03601 Martin, Slovakia				The role of plasma membrane CA²⁺ Pumps (PMCAs) in pathologies of mammalian cells	[Frontiers in Bioscience 7, d53-84, January 1, 2002]	11779702
Radovan	Murín	Malá Hora 4, SK-03601 Martin, Slovakia				The role of plasma membrane CA²⁺ Pumps (PMCAs) in pathologies of mammalian cells	[Frontiers in Bioscience 7, d53-84, January 1, 2002]	11779702
Luc	Raeymaekers	K.U.Leuven, Campus Gasthuisberg, B-3000 LEUVEN, Belgium				The role of plasma membrane CA²⁺ Pumps (PMCAs) in pathologies of mammalian cells	[Frontiers in Bioscience 7, d53-84, January 1, 2002]	11779702
T. Mustelin		The Burnham Institute, La Jolla Cancer Research Center, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA	tmustelin@burnham-inst.org	858- 713-6274	858-713-6270	Protein tyrosine phosphatases	[Frontiers in Bioscience 7, d85-142, January 1, 2002]	11779706
G.-S. Feng,		The Burnham Institute, La Jolla Cancer Research Center, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA				Protein tyrosine phosphatases	[Frontiers in Bioscience 7, d85-142, January 1, 2002]	11779706
N. Bottini		The Burnham Institute, La Jolla Cancer Research Center, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA				Protein tyrosine phosphatases	[Frontiers in Bioscience 7, d85-142, January 1, 2002]	11779706
Alonso, N. Kholod		The Burnham Institute, La Jolla Cancer Research Center, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA				Protein tyrosine phosphatases	[Frontiers in Bioscience 7, d85-142, January 1, 2002]	11779706
D. Birle		The Burnham Institute, La Jolla Cancer Research Center, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA				Protein tyrosine phosphatases	[Frontiers in Bioscience 7, d85-142, January 1, 2002]	11779706
J. Merlo		The Burnham Institute, La Jolla Cancer Research Center, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA				Protein tyrosine phosphatases	[Frontiers in Bioscience 7, d85-142, January 1, 2002]	11779706
H. Huynh		The Burnham Institute, La Jolla Cancer Research Center, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA				Protein tyrosine phosphatases	[Frontiers in Bioscience 7, d85-142, January 1, 2002]	11779706
Tracee S. Panetti		Temple University School of Medicine, Philadelphia, PA 19140	tpanetti@temple.edu	215-707-5149	215-707-2879	Tyrosine phosphorylation of paxillin, FAK, AND p130CAS: effects on cell spreading and migration	[Frontiers in Bioscience 7, d143-150, January 1, 2002]	11779709
Xiangwei Wu		Baylor College of Medicine, Houston, TX 77030	xiangwei@bcm.tmc.edu	713-798-1566	713-798-4161	BAX and BH3-domain-only proteins in p53-mediated apoptosis	[Frontiers in Bioscience 7, d151-156, January 1, 2002]	11779719
Yibin Deng		Baylor College of Medicine, Houston, TX 77030				BAX and BH3-domain-only proteins in p53-mediated apoptosis	[Frontiers in Bioscience 7, d151-156, January 1, 2002]	11779719
Christine Neuveut		Institut Pasteur, 28, rue du Dr Roux. 75724 Paris cedex 15, France				Cell cycle dysregulation by HTLV-I: role of the TAX oncoprotein	[Frontiers in Bioscience 7, d157-163, January 1, 2002]	11779707
Kuan-Teh Jeang		National Institute of Allergy and Infectious Diseases, Building 4 Room 306, 9000 Rockville Pike, Bethesda MD 20892-0460	kj7e@nih.gov	301 480-3686	301 496-6680	Cell cycle dysregulation by HTLV-I: role of the TAX oncoprotein	[Frontiers in Bioscience 7, d157-163, January 1, 2002]	11779707
Lidia Cherezova		West Virginia University, Morgantown, WV				The effects of phosphorylation on adaptor protein function	[Frontiers in Bioscience 7, d164-203, January 1, 2002]	11779691
Amanda Gatesman		West Virginia University, Morgantown, WV				The effects of phosphorylation on adaptor protein function	[Frontiers in Bioscience 7, d164-203, January 1, 2002]	11779691
Daniel C. Flynn		West Virginia University, Morgantown, WV	dflynn@hsc.wvu.edu	304-293-7584	304-293-6966	The effects of phosphorylation on adaptor protein function	[Frontiers in Bioscience 7, d164-203, January 1, 2002]	11779691
Masataka	Okuno	Gifu University School of Medicine, Gifu, Japan	mokuno@cc.gifu-u.ac.jp	+81-58-262-8484	+81-58-267-2843	Retinoids in liver fibrosis and cancer	[Frontiers in Bioscience 7, d204-218, January 1, 2002]	11779708
Annika	Armulik	Uppsala University, S-751 23, Uppsala, Sweden	Annika.Armulik@cmb.ki.se	+46-8-30-83-74	+46-8-728 7271	Splice variants of human b1 integrins: origin, biosynthesis and functions	[Frontiers in Bioscience 7, d219-227, January 1, 2002]	11779688
Federica Benvenuti		Institute Curie, INSERM U520, 12 Rue Lhomond, 75005 Paris,				Anti-idiotypic DNA vaccines for B-cell lymphoma therapy	[Frontiers in Bioscience 7, d228-234, January 1, 2002]	11779689
Michela Cesco-Gaspere		International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34012-Trieste, Italy				Anti-idiotypic DNA vaccines for B-cell lymphoma therapy	[Frontiers in Bioscience 7, d228-234, January 1, 2002]	11779689
Oscar R. Burrone		International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34012-Trieste, Italy	burrone@icgeb.trieste.it	+39-040-226555	+39-040-3757314	Anti-idiotypic DNA vaccines for B-cell lymphoma therapy	[Frontiers in Bioscience 7, d228-234, January 1, 2002]	11779689
Swati Palit Deb		Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298	spdeb@hsc.vcu.edu	804-827-1427	804-828-9541	Function and dysfunction of the human oncoprotein MDM2	[Frontiers in Bioscience 7, d235-243, January 1, 2002]	11779693
Colin Longstaff		National Institute for Biological Standards and Control, South Mimms, Herts UK, EN6 3QG	clongstaff@nibsc.ac.uk	+44 01707 646730	+44 01707 654753	Plasminogen activation on the cell surface	[Frontiers in Bioscience 7, d244-255, January 1, 2002]	11779703
Patricia Pellicena		The Rockefeller University, 1230 York Avenue, New York, NY 10021				Coupling kinase activation to substrate recognition in SRC-family tyrosine kinases	[Frontiers in Bioscience 7, d256-267, January 1, 2002]	11779710
W. Todd Miller		State University of New York at Stony Brook, Stony Brook, NY 11794	miller@physiology.pnb.sunysb.edu	631-444-3432	631-444-3533	Coupling kinase activation to substrate recognition in SRC-family tyrosine kinases	[Frontiers in Bioscience 7, d256-267, January 1, 2002]	11779710
George Klein		Karolinska Institutet, S-171 77 Stockholm, Sweden	georg.klein@mtc.ki.se	+46 8 33 04 98	+46 8 728 67 30	Perspectives in studies of human tumor viruses	[Frontiers in Bioscience 7, d268-274, January 1, 2002]	11779700
Jean-Louis Frossard		Hôpital Cantonal Universitaire de Genève, Geneva, Switzerland	jean-louis.frossard@hcuge.ch	41 22 372 93	41 22 372 93 40	Experimental acute pancreatitis: new insights into the pathophysiology	[Frontiers in Bioscience 7, d275-287, January 1, 2002]	11779694
Catherine M Pastor		Hôpital Cantonal Universitaire de Genève, Geneva, Switzerland				Experimental acute pancreatitis: new insights into the pathophysiology	[Frontiers in Bioscience 7, d275-287, January 1, 2002]	11779694
Brian E. Hall		State University of New York at Stony Brook, Stony Brook, New York 11794-5222				Autoinhibition of SOS by intramolecular interactions	[Frontiers in Bioscience 7, d288-294, January 1, 2002]	11779695
Shao-Song Yang		State University of New York at Stony Brook, Stony Brook, New York 11794-5222				Autoinhibition of SOS by intramolecular interactions	[Frontiers in Bioscience 7, d288-294, January 1, 2002]	11779695
Dafna Bar-Sagi		State University of New York at Stony Brook, Stony Brook, New York 11794-5222	barsagi@pharm.sunysb.edu	631-632-8891	631-632-9737	Autoinhibition of SOS by intramolecular interactions	[Frontiers in Bioscience 7, d288-294, January 1, 2002]	11779695
Robert F. Kalejta		Princeton University, Princeton NJ 08544-1014				Manipulation of the cell cycle by human cytomegalovirus	[Frontiers in Bioscience 7, d295-306, January 1, 2002]	11779699
Thomas Shenk		Princeton University, Princeton NJ 08544-1014	tshenk@princeton.edu	609-258-1704	609-258-5992	Manipulation of the cell cycle by human cytomegalovirus	[Frontiers in Bioscience 7, d295-306, January 1, 2002]	11779699
Ida W. Smoak		North Carolina State University, 4700 Hillsborough Street, Raleigh, NC 27606	ida_smoak@ncsu.edu	919-513-6465	919-513-6322	Hypoglycemia and embryonic heart development	[Frontiers in Bioscience 7, d307-318, January 1, 2002]	11779716
Eudoxia Hatzivassiliou		Aristotle University of Thessaloniki, Thessaloniki 54006, Greece				Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1	[Frontiers in Bioscience 7, d319-329, January 1, 2002]	11779697
George Mosialos		Biomedical Sciences Research Center Al. Fleming, 14-16 Al. Fleming Str., Vari 16672, Greece	mosialos@fleming.gr	30-1-9653934	30-1-9656310	Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1	[Frontiers in Bioscience 7, d319-329, January 1, 2002]	11779697
Stevan R. Hubbard		New York University School of Medicine, New York, NY 10016	hubbard@saturn.med.nyu.edu	212-263-8951	212-263-8938	Autoinhibitory mechanisms in receptor tyrosine kinases	[Frontiers in Bioscience 7, d330-340, February 1, 2002]	11815286
Jiyun Kim		Weill Medical College of Cornell University, Box 45, 1300 York Avenue, New York, NY				Annexin II: a plasminogen-plasminogen activator co-receptor	[Frontiers in Bioscience 7, d341-348, February 1, 2002]	11815288
Katherine A. Hajjar		Weill Medical College of Cornell University, Box 45, 1300 York Avenue, New York, NY	khajjar@med.cornell.edu	212-746-8809	212-746-2034	Annexin II: a plasminogen-plasminogen activator co-receptor	[Frontiers in Bioscience 7, d341-348, February 1, 2002]	11815288
Robert T. Elder		Northwestern University Medical School, 2430 N Halsted Street, MB218, Chicago, Illinois 60614				HIV-1 VPR modulates cell cycle G2/M transition through an alternative cellular mechanism other than the classic mitotic checkpoints	[Frontiers in Bioscience 7, d349-357, February 1, 2002]	11815283
Zsigmond Benko		Northwestern University Medical School, 2430 N Halsted Street, MB218, Chicago, Illinois 60614				HIV-1 VPR modulates cell cycle G2/M transition through an alternative cellular mechanism other than the classic mitotic checkpoints	[Frontiers in Bioscience 7, d349-357, February 1, 2002]	11815283
Yuqi Zhao		Northwestern University Medical School, 2430 N Halsted Street, MB218, Chicago, Illinois 60614	yzhao@northwestern.edu	773-880-6609	773-880-6608	HIV-1 VPR modulates cell cycle G2/M transition through an alternative cellular mechanism other than the classic mitotic checkpoints	[Frontiers in Bioscience 7, d349-357, February 1, 2002]	11815283
Murray A. Cotter		University of Michigan Medical School, Ann Arbor, MI				Molecular biology of Kaposi's sarcoma-associated herpesvirus	[Frontiers in Bioscience 7, d358-375, February 1, 2002]	11815281
Erle S. Robertson		University of Michigan Medical School, Ann Arbor, MI	esrobert@umich.edu	734-647-9647	734-647-7296	Molecular biology of Kaposi's sarcoma-associated herpesvirus	[Frontiers in Bioscience 7, d358-375, February 1, 2002]	11815281
Steven Grant		Medical College of Virginia,Virginia Commonwealth University, Richmond VA 23298-0058				Roles of Erbb family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival	[Frontiers in Bioscience 7, d376-389, February 1, 2002]	11815285
Liang Qiao		Medical College of Virginia,Virginia Commonwealth University, Richmond VA 23298-0058				Roles of Erbb family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival	[Frontiers in Bioscience 7, d376-389, February 1, 2002]	11815285
Paul Dent		Medical College of Virginia,Virginia Commonwealth University, Richmond VA 23298-0058	pdent@hsc.vcu.edu	804-828-6042	804-628-0861	Roles of Erbb family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival	[Frontiers in Bioscience 7, d376-389, February 1, 2002]	11815285
Oveta Fuller		University of Michigan School of Medicine, Ann Arbor, MI 48109-0620	fullerao@umich.edu		734-764-3562	Mechanisms of DNA virus infection: entry and early events	[Frontiers in Bioscience 7, d390-406, February 1, 2002]	11815295
Pilar Perez-Romero		University of Michigan School of Medicine, Ann Arbor, MI 48109-0620				Mechanisms of DNA virus infection: entry and early events	[Frontiers in Bioscience 7, d390-406, February 1, 2002]	11815295
Nianli Sang		Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107	nsang123@yahoo.com	215-955-5118	215-923-3836	Adenoviral E1A: everlasting tool, versatile applications, continuous contributions and new hypotheses	[Frontiers in Bioscience 7, d407-413, Feburary 1, 2002]	11815298
Jaime Caro		Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107				Adenoviral E1A: everlasting tool, versatile applications, continuous contributions and new hypotheses	[Frontiers in Bioscience 7, d407-413, Feburary 1, 2002]	11815298
Antonio Giordano		Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107				Adenoviral E1A: everlasting tool, versatile applications, continuous contributions and new hypotheses	[Frontiers in Bioscience 7, d407-413, Feburary 1, 2002]	11815298
Toni Portis		Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois, 60611				The LMP2A signalosome - a therapeutic target for Epstein-Barr virus latency and associated disease	[Frontiers in Bioscience 7, d414-426, Feburary 1, 2002]	11815296
Lori Cooper		Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois, 60611				The LMP2A signalosome - a therapeutic target for Epstein-Barr virus latency and associated disease	[Frontiers in Bioscience 7, d414-426, Feburary 1, 2002]	11815296
Patrick Dennis		Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois, 60611				The LMP2A signalosome - a therapeutic target for Epstein-Barr virus latency and associated disease	[Frontiers in Bioscience 7, d414-426, Feburary 1, 2002]	11815296
Richard Longnecker		Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois, 60611	r-longnecker@northwestern.edu	312-503-0467	312-503-1339	The LMP2A signalosome - a therapeutic target for Epstein-Barr virus latency and associated disease	[Frontiers in Bioscience 7, d414-426, Feburary 1, 2002]	11815296
Trevor Owens		Montreal Neurological Institute, 3801 University St., Montreal, Qc, Canada H3A 2B4	Trevor@med.mcgill.ca	514-398-5036	514-398-7371	Immune response induction in the central nervous system	[Frontiers in Bioscience 7, d427-438, Feburary 1, 2002]	11815294
Alicia Babcock		Montreal Neurological Institute, 3801 University St., Montreal, Qc, Canada H3A 2B4				Immune response induction in the central nervous system	[Frontiers in Bioscience 7, d427-438, Feburary 1, 2002]	11815294
Hongwei Yu		Joan C. Edwards School of Medicine at Marshall University, 1542 Spring Valley Drive, Huntington, WV 25704				Persistent infections and immunity in cystic fibrosis	[Frontiers in Bioscience 7, d442-457, Feburary 1, 2002]	11815305
Nathan E. Head		Joan C. Edwards School of Medicine at Marshall University, 1542 Spring Valley Drive, Huntington, WV 25704	Yuh@marshall.edu	304-696-7356	304-696-7207	Persistent infections and immunity in cystic fibrosis	[Frontiers in Bioscience 7, d442-457, Feburary 1, 2002]	11815305
Timo Ulrichs		Max-Planck-Institute for Infection Biology, Schumannstraße 21/22, 10117 Berlin, Germany				Mycobacterial persistence and immunity	[Frontiers in Bioscience 7, d458-469, Feburary 1, 2002]	11815304
Stefan H. E. Kaufmann		Max-Planck-Institute for Infection Biology, Schumannstraße 21/22, 10117 Berlin, Germany	ulrichs@mpiib-berlin.mpg.de	49[0]30 28 46 0500	49[0]30 28 46 0501	Mycobacterial persistence and immunity	[Frontiers in Bioscience 7, d458-469, Feburary 1, 2002]	11815304
Kazuyoshi Ikuta		Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan	ikuta@biken.osaka-u.ac.jp	+81 6 6879-8307	. +81 6 6879-8310.	Borna disease virus and infection in humans	[Frontiers in Bioscience 7, d470-495, Feburary 1, 2002]	11815287
Madiha S. Ibrahim		Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan				Borna disease virus and infection in humans	[Frontiers in Bioscience 7, d470-495, Feburary 1, 2002]	11815287
Takeshi Kobayashi		Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan				Borna disease virus and infection in humans	[Frontiers in Bioscience 7, d470-495, Feburary 1, 2002]	11815287
Keizo Tomonaga		Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan				Borna disease virus and infection in humans	[Frontiers in Bioscience 7, d470-495, Feburary 1, 2002]	11815287
Nils Kinnman		Karolinska Hospital, Karolinska Institute, 171 76 Stockholm, Sweden	kinnman@st-antoine.inserm.fr	33 - 1 - 40 01 13 26	33 - 1 - 40 01 14 99	Peribiliary myofibroblasts in biliary type liver fibrosis	[Frontiers in Bioscience 7, d496-503, Feburary 1, 2002]	11815289
Chantal Housset		Karolinska Hospital, Karolinska Institute, 171 76 Stockholm, Sweden				Peribiliary myofibroblasts in biliary type liver fibrosis	[Frontiers in Bioscience 7, d496-503, Feburary 1, 2002]	11815289
Takayuki Miyazawa		Research Institute for Microbial Diseases, 3-1 Yamadaoka, Suita-city, Osaka 565-0871, Japan	takavet@mc.kcom.ne.jp	+81-6-6879-8343.	+81-6-6879-8269	Infections of feline leukemia virus and feline immunodeficiency virus	[Frontiers in Bioscience 7, d504-518, Feburary 1, 2002]	11815291
PG Murray		University of Birmingham, Birmingham, B15 2TT, UK				The role of the Epstein-Barr virus in human disease	[Frontiers in Bioscience 7, d519-540, Feburary 1, 2002]	11815292
LS Young		University of Birmingham, Birmingham, B15 2TT, UK	L.S.Young@bham.ac.uk	+44 0 121 414 6876	+44 0121 414 5376	The role of the Epstein-barr virus in human disease	[Frontiers in Bioscience 7, d519-540, Feburary 1, 2002]	11815292
Lothar Stitz		Paul-Ehrlich-Strasse 28, D-72076 Tübingen, FRG	lothar.stitz@tue.bfav.de	+49 7071 967 106	+49 7071 967 105	The immunopathogenesis of Borna disease virus infection	[Frontiers in Bioscience 7, d541-555, Feburary 1, 2002]	11815301
Thomas Bilzer		Heinrich-Heine-Universität, Düsseldorf, FRG				The immunopathogenesis of Borna disease virus infection	[Frontiers in Bioscience 7, d541-555, Feburary 1, 2002]	11815301
Oliver Planz		Paul-Ehrlich-Strasse 28, D-72076 Tübingen, FRG				The immunopathogenesis of Borna disease virus infection	[Frontiers in Bioscience 7, d541-555, Feburary 1, 2002]	11815301
						The immunopathogenesis of Borna disease virus infection	[Frontiers in Bioscience 7, d541-555, Feburary 1, 2002]
Mariko Nagashima		Berlex Biosciences, Richmond, CA, USA.	Mariko_Nagashima@berlex.com	510-669-4136	510-669-4246	Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice	[Frontiers in Bioscience 7, d556-568, Feburary 1, 2002]	11815293
Zheng-Feng Yin		Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis, MO				Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice	[Frontiers in Bioscience 7, d556-568, Feburary 1, 2002]	11815293
George J. Broze		Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis, MO				Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice	[Frontiers in Bioscience 7, d556-568, Feburary 1, 2002]	11815293
John Morser		Berlex Biosciences, Richmond, CA, USA.				Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice	[Frontiers in Bioscience 7, d556-568, Feburary 1, 2002]	11815293
Juan Carlos de la Torre		The Scripps Research Institute, 10550 North Torrey Pines Rd, La Jolla, CA 92037	juanct@scripps.edu	858-7849462	858-7849981	Molecular biology of Borna disease virus and persistence	[Frontiers in Bioscience 7, d569-579, Feburary 1, 2002]	11815302
Sharron H. Francis		Vanderbilt University School of Medicine, Nashville, TN 37232-0615	sharron.francis@mcmail.vanderbilt.edu	615-322-4383	615-343-3794	Mechanisms of autoinhibition in cyclic nucleotide-dependent protein kinases	[Frontiers in Bioscience 7, d580-592, March 1, 2002]	11861209
Celeste Poteet-Smith		Vanderbilt University School of Medicine, Nashville, TN 37232-0615				Mechanisms of autoinhibition in cyclic nucleotide-dependent protein kinases	[Frontiers in Bioscience 7, d580-592, March 1, 2002]	11861209
Jennifer L. Busch		Vanderbilt University School of Medicine, Nashville, TN 37232-0615				Mechanisms of autoinhibition in cyclic nucleotide-dependent protein kinases	[Frontiers in Bioscience 7, d580-592, March 1, 2002]	11861209
Robyn Richie-Jannetta		Vanderbilt University School of Medicine, Nashville, TN 37232-0615				Mechanisms of autoinhibition in cyclic nucleotide-dependent protein kinases	[Frontiers in Bioscience 7, d580-592, March 1, 2002]	11861209
Jackie D. Corbin		Vanderbilt University School of Medicine, Nashville, TN 37232-0615				Mechanisms of autoinhibition in cyclic nucleotide-dependent protein kinases	[Frontiers in Bioscience 7, d580-592, March 1, 2002]	11861209
Mikhail V. Pletnikov		The Johns Hopkins University School of Medicine, Ross 618, 720 Rutland Avenue, Baltimore, MD 21205	pletnikov@cbs5055530.cber.FDA.gov	410-955-2996	410-614-0013	Borna disease virus infection of the neonatal rat: Developmental brain injury model of autism spectrum disorders	[Frontiers in Bioscience 7, d593-607, March 1, 2002]	11861216
Timothy H. Moran		The Johns Hopkins University School of Medicine, Ross 618, 720 Rutland Avenue, Baltimore, MD 21205				Borna disease virus infection of the neonatal rat: Developmental brain injury model of autism spectrum disorders	[Frontiers in Bioscience 7, d593-607, March 1, 2002]	11861216
Kathryn M. Carbone		The Johns Hopkins University School of Medicine, Ross 618, 720 Rutland Avenue, Baltimore, MD 21205				Borna disease virus infection of the neonatal rat: Developmental brain injury model of autism spectrum disorders	[Frontiers in Bioscience 7, d593-607, March 1, 2002]	11861216
Maria Trojanowska		University of South Carolina, 96 Jonathan Lucas St., Suite 912, Charleston SC 29425	trojanme@musc.edu	843-792-7921	843-792-7121	Molecular aspects of scleroderma	[Frontiers in Bioscience 7, d608-618, March 1, 2002]	11861221
Gail E. Gasparich		Towson University, 8000 York Road, Towson, MD 21252	ggasparich@towson.edu	410-704-4515	410-704-2405	Spiroplasmas: evolution, adaptation and diversity	[Frontiers in Bioscience 7, d619-640, March 1, 2002]	11861210
Karl Münger		Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115-5701	karl_munger@hms.harvard.edu	617-432-2878	617-432-0426	The role of human papillomaviruses in human cancers	[Frontiers in Bioscience 7, d641-649, March 1, 2002]	11861215
Feliciano Protasi		Harvard Medical School, Boston MA 02115	protasi@zeus.bwh.harvard.edu	617-732 6881	617-732 6927	Structural interaction between RYRs and DHPRs in calcium release units of cardiac and skeletal muscle cells	[Frontiers in Bioscience 7, d650-658, March 1, 2002]	11861217
Robert T. Dirksen		University of Rochester School of Medicine and Dentistry, Rochester, NY, 14534	Robert_Dirksen@URMC.Rochester.edu	585-275-4824	585-273-2652	Bi-directional coupling between dihydropyridine receptors and ryanodine receptors	[Frontiers in Bioscience 7, d659-670, March 1, 2002]	11861208
Noriaki Ikemoto		Boston Biomedical Research Institute, Watertown, MA	ikemoto@bbri.org	617-658-7774	617-972-1761	Regulation of calcium release by interdomain interaction within ryanodine receptors	[Frontiers in Bioscience 7, d671-683, March 1, 2002]	11861212
Takeshi Yamamoto		Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115-5701				Regulation of calcium release by interdomain interaction within ryanodine receptors	[Frontiers in Bioscience 7, d671-683, March 1, 2002]	11861212
Stephen E. Ullrich		The University of Texas, M. D. Anderson Cancer Center, Houston, Texas, USA	sullrich@mdanderson.org	713 792-8593	713 745-1633	Photoimmune suppression and photocarcinogenesis	[Frontiers in Bioscience 7, d684-703, March 1, 2002]	11861222
Chitra Subramanian		University of Michigan Medical School, Ann Arbor, MI				The Epstein Barr Nuclear Antigen EBNA3C regulates transcription, cell transformation and cell migration	[Frontiers in Bioscience 7, d704-716, March 1, 2002]	11861219
Jason S. Knight		University of Michigan Medical School, Ann Arbor, MI				The Epstein Barr Nuclear Antigen EBNA3C regulates transcription, cell transformation and cell migration	[Frontiers in Bioscience 7, d704-716, March 1, 2002]	11861219
Erle S. Robertson		University of Michigan Medical School, Ann Arbor, MI	esrobert@umich.edu	734-647-7296	734-647-9647	The Epstein Barr Nuclear Antigen EBNA3C regulates transcription, cell transformation and cell migration	[Frontiers in Bioscience 7, d704-716, March 1, 2002]	11861219
Jian Wu		University of California, Davis Medical Center, Sacramento, CA 95817	jdwu@ucdavis.edu	916-734-8044	916-734-8097	Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications	[Frontiers in Bioscience 7, d717-725, March 1, 2002]	11861224
Michael H. Nantz		University of California, Davis Medical Center, Sacramento, CA 95817				Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications	[Frontiers in Bioscience 7, d717-725, March 1, 2002]	11861224
Mark A. Zern		University of California, Davis Medical Center, Sacramento, CA 95817				Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications	[Frontiers in Bioscience 7, d717-725, March 1, 2002]	11861224
Takashi Komatsu		Harvard Medical School, 181 Longwood Ave.,Boston, MA				The KSHV latency-associated nuclear antigen: a multifunctional protein	[Frontiers in Bioscience 7, d726-730, March 1, 2002]	11861213
Mary E. Ballestas		Harvard Medical School, 181 Longwood Ave.,Boston, MA				The KSHV latency-associated nuclear antigen: a multifunctional protein	[Frontiers in Bioscience 7, d726-730, March 1, 2002]	11861213
Andrew J. Barbera		Harvard Medical School, 181 Longwood Ave.,Boston, MA				The KSHV latency-associated nuclear antigen: a multifunctional protein	[Frontiers in Bioscience 7, d726-730, March 1, 2002]	11861213
Kenneth M. Kaye		Harvard Medical School, 181 Longwood Ave.,Boston, MA	kkaye@rics.bwh.harvard.edu	617-525-4256	617-525-4251	The KSHV latency-associated nuclear antigen: a multifunctional protein	[Frontiers in Bioscience 7, d726-730, March 1, 2002]	11861213
Zihai Li		University of Connecticut School of Medicine, Farmington, CT	zli@up.uchc.edu	860-679-7979	860-679-1265	An integrated view of the roles and mechanisms of heat shock protein GP96-peptide complex in eliciting immune response	[Frontiers in Bioscience 7, d731-751, March 1, 2002]	11861214
Jie Dai		University of Connecticut School of Medicine, Farmington, CT				An integrated view of the roles and mechanisms of heat shock protein GP96-peptide complex in eliciting immune response	[Frontiers in Bioscience 7, d731-751, March 1, 2002]	11861214
Hong Zheng		University of Connecticut School of Medicine, Farmington, CT				An integrated view of the roles and mechanisms of heat shock protein GP96-peptide complex in eliciting immune response	[Frontiers in Bioscience 7, d731-751, March 1, 2002]	11861214
Bei Liu		University of Connecticut School of Medicine, Farmington, CT				An integrated view of the roles and mechanisms of heat shock protein GP96-peptide complex in eliciting immune response	[Frontiers in Bioscience 7, d731-751, March 1, 2002]	11861214
Marissa Caudill		University of Connecticut School of Medicine, Farmington, CT				An integrated view of the roles and mechanisms of heat shock protein GP96-peptide complex in eliciting immune response	[Frontiers in Bioscience 7, d731-751, March 1, 2002]	11861214
Travis J Taylor		Harvard Medical School, Department of Microbiology and Molecular Genetics, 200 Longwood Avenue, Boston, MA 02115				Herpes Simplex Virus	[Frontiers in Bioscience 7, d752-764, March 1, 2002]	11861220
Mark A. Brockman		Harvard Medical School, Department of Microbiology and Molecular Genetics, 200 Longwood Avenue, Boston, MA 02115				Herpes Simplex Virus	[Frontiers in Bioscience 7, d752-764, March 1, 2002]	11861220
Elizabeth E. McNamee		Harvard Medical School, Department of Microbiology and Molecular Genetics, 200 Longwood Avenue, Boston, MA 02115				Herpes Simplex Virus	[Frontiers in Bioscience 7, d752-764, March 1, 2002]	11861220
David M. Knipe		Harvard Medical School, Department of Microbiology and Molecular Genetics, 200 Longwood Avenue, Boston, MA 02115	david_knipe@hms.harvard.edu	617-432-1934	617-432-0223	Herpes Simplex Virus	[Frontiers in Bioscience 7, d752-764, March 1, 2002]	11861220
Yasuhiro Matsumura		University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 178, Houston, TX, 77030				Molecular mechanisms of photocarcinogenesis	[Frontiers in Bioscience 7, d765-783, April 1, 2002]	11897559
Honnavara N. Ananthaswamy		University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 178, Houston, TX, 77030	hanantha@mdanderson.org	713-792-8595	713-794-1322	Molecular mechanisms of photocarcinogenesis	[Frontiers in Bioscience 7, d765-783, April 1, 2002]	11897559
Farrukh Afaq		Case Western Reserve University and The Research Institute of University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, Ohio 44106				Botanical antioxidants for chemoprevention of photocarcinogenesis	[Frontiers in Bioscience 7, d784-792, April 1, 2002]	11897547
Vaqar M Adhami		Case Western Reserve University and The Research Institute of University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, Ohio 44106				Botanical antioxidants for chemoprevention of photocarcinogenesis	[Frontiers in Bioscience 7, d784-792, April 1, 2002]	11897547
Nihal Ahmad		Case Western Reserve University and The Research Institute of University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, Ohio 44106				Botanical antioxidants for chemoprevention of photocarcinogenesis	[Frontiers in Bioscience 7, d784-792, April 1, 2002]	11897547
Hasan Mukhtar		Case Western Reserve University and The Research Institute of University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, Ohio 44106	hxm4@po.cwru.edu	216-368-1127	216-368-0212	Botanical antioxidants for chemoprevention of photocarcinogenesis	[Frontiers in Bioscience 7, d784-792, April 1, 2002]	11897547
Axel M. Gressner		RWTH-University Hospital, D-52074 Aachen, Germany	agressner@ukaachen.de		++49-0241-80-82-512	Roles of TGF-beta in hepatic fibrosis	[Frontiers in Bioscience 7, d793-807, April 1, 2002]	11897555
Ralf Weiskirchen		RWTH-University Hospital, D-52074 Aachen, Germany				Roles of TGF-beta in hepatic fibrosis	[Frontiers in Bioscience 7, d793-807, April 1, 2002]	11897555
Katja Breitkopf		RWTH-University Hospital, D-52074 Aachen, Germany				Roles of TGF-beta in hepatic fibrosis	[Frontiers in Bioscience 7, d793-807, April 1, 2002]	11897555
Steven Dooley		RWTH-University Hospital, D-52074 Aachen, Germany				Roles of TGF-beta in hepatic fibrosis	[Frontiers in Bioscience 7, d793-807, April 1, 2002]	11897555
Helen L Reeves		Mount Sinai School of Medicine, New York, NY 10029-6574	Hal1@doctors.org.uk	212-659-9523	212-849-2574	Activation of hepatic stellate cells - a key issue in liver fibrosis	[Frontiers in Bioscience 7, d808-826, April 1, 2002]	11897564
Scott L Friedman		Mount Sinai School of Medicine, New York, NY 10029-6574	frieds02@doc.mssm.edu	212-659-9501	212-849- 2574	Activation of hepatic stellate cells - a key issue in liver fibrosis	[Frontiers in Bioscience 7, d808-826, April 1, 2002]	11897564
Alister C. Ward		Deakin University, Burwood, Victoria 3125, Australia	award@deakin.edu.au	61-3-9244-6708	61-3-9251-7328	The zebrafish as a model system for human disease	[Frontiers in Bioscience 7, d827-833, April 1, 2002]	11897571
Graham J. Lieschke		The Royal Melbourne Hospital, Victoria 3050, Australia				The zebrafish as a model system for human disease	[Frontiers in Bioscience 7, d827-833, April 1, 2002]	11897571
Graham D. Lamb		La Trobe University, Melbourne, Victoria, 3086, Australia	zoogl@zoo.latrobe.edu.au	61-3-94792249	61-3-94791551	Voltage-sensor control of Ca2+ release in skeletal muscle: insights from skinned fibers	[Frontiers in Bioscience 7, d834-842, April 1, 2002]	11897557
Andrew W. Trafford		The University of Manchester, 1.524 Stopford Building, Oxford Rd, Manchester M13 9PT, U.K.	eisner@man.ac.uk	+44 161 275 2702	+44 161 275 2703	Integrative analysis of calcium signalling in cardiac muscle	[Frontiers in Bioscience 7, d843-852, April 1, 2002]	11897570
M.E. Díaz		The University of Manchester, 1.524 Stopford Building, Oxford Rd, Manchester M13 9PT, U.K.				Integrative analysis of calcium signalling in cardiac muscle	[Frontiers in Bioscience 7, d843-852, April 1, 2002]	11897570
S.C. O'Neill		The University of Manchester, 1.524 Stopford Building, Oxford Rd, Manchester M13 9PT, U.K.				Integrative analysis of calcium signalling in cardiac muscle	[Frontiers in Bioscience 7, d843-852, April 1, 2002]	11897570
D.A. Eisner		The University of Manchester, 1.524 Stopford Building, Oxford Rd, Manchester M13 9PT, U.K.				Integrative analysis of calcium signalling in cardiac muscle	[Frontiers in Bioscience 7, d843-852, April 1, 2002]	11897570
Ryan A. Wilcox		Mayo Clinic, Rochester, MN 55905	chen.lieping@mayo.edu	507-538-0013	507-284-1637	Immunotherapy of human papillomavirus-associated malignancies and the challenges posed by T-CELL tolerance	[Frontiers in Bioscience 7, d853-871, April 1, 2002]	11897572
Lieping Chen		Mayo Clinic, Rochester, MN 55905				Immunotherapy of human papillomavirus-associated malignancies and the challenges posed by T-CELL tolerance	[Frontiers in Bioscience 7, d853-871, April 1, 2002]	11897572
Craig Blackstone		National Institutes of Health, Building 36, Room 5W21, 9000 Rockville Pike, Bethesda, MD 20892				Postsynaptic calcium signaling microdomains in neurons	[Frontiers in Bioscience 7, d872-885, April 1, 2002]	11897549
Morgan Sheng		RIKEN-MIT Neuroscience Research Center, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139	blackstc@ninds.nih.gov	301-451-9680	301-480-4888	Postsynaptic calcium signaling microdomains in neurons	[Frontiers in Bioscience 7, d872-885, April 1, 2002]	11897549
Peter Storz		Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215				3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling	[Frontiers in Bioscience 7, d886-902, April 1, 2002]	11897568
Alex Toker		Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215	atoker@caregroup.harvard.edu	617-667-8535	617-667-3616	3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling	[Frontiers in Bioscience 7, d886-902, April 1, 2002]	11897568
Guoqiang Jiang		Merck Research Laboratories, RY80N-C31, P.O Box 2000, Rahway, NJ 07065				PI 3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetes	[Frontiers in Bioscience 7, d903-917, April 1, 2002]	11897556
Bei B. Zhang		Merck Research Laboratories, RY80N-C31, P.O Box 2000, Rahway, NJ 07065	guoqiang_jiang@merck.com	732-594- 2176	732-594-3925	PI 3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetes	[Frontiers in Bioscience 7, d903-917, April 1, 2002]	11897556
Tomas Mustelin		The Burnham Institute, La Jolla, CA 92037	tmustelin@burnham-inst.org	858-713-6270	858- 713-6274	Protein tyrosine phosphorylation in T cell signaling	[Frontiers in Bioscience 7, d918-969, April 1, 2002]	11897562
Robert T. Abraham		The Burnham Institute, La Jolla, CA 92037				Protein tyrosine phosphorylation in T cell signaling	[Frontiers in Bioscience 7, d918-969, April 1, 2002]	11897562
Christopher E. Rudd		Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston MA 02115				Protein tyrosine phosphorylation in T cell signaling	[Frontiers in Bioscience 7, d918-969, April 1, 2002]	11897562
Andres Alonso		The Burnham Institute, La Jolla, CA 92037				Protein tyrosine phosphorylation in T cell signaling	[Frontiers in Bioscience 7, d918-969, April 1, 2002]	11897562
Joseph J. Merlo		The Burnham Institute, La Jolla, CA 92037				Protein tyrosine phosphorylation in T cell signaling	[Frontiers in Bioscience 7, d918-969, April 1, 2002]	11897562
Andrew R. Marks		Columbia University College of Physicians and Surgeons, New York, N.Y. 10032	arm42@columbia.edu	212-305-0270	212 305-3690	Ryanodine receptors, FKBP12, and heart failure	[Frontiers in Bioscience 7, d970-977, April 1, 2002]	11897558
Frederick K. Racke		Johns Hopkins University, Baltimore, MD 21287				Control of myeloid dendritic cell differentiation and function by CD1d-restricted (NK) T cells	[Frontiers in Bioscience 7, d978-985, April 1, 2002]	11897563
Michael Clare-Salzer		University of Florida, Gainesville, Floridaa 32610				Control of myeloid dendritic cell differentiation and function by CD1d-restricted (NK) T cells	[Frontiers in Bioscience 7, d978-985, April 1, 2002]	11897563
S. Brian Wilson		Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115	brian_wilson@dfci.harvard.edu	617-632-2662	617- 632-2662	Control of myeloid dendritic cell differentiation and function by CD1d-restricted (NK) T cells	[Frontiers in Bioscience 7, d978-985, April 1, 2002]	11897563
David H. Small		University of Melbourne, Victoria 3010, Australia	davidhs@unimelb.edu.au	61-3-8344-4205	. 61-3-8344-4004	Alzheimer's disease biomarkers: their value in diagnosis and clinical trials	[Frontiers in Bioscience 7, d986-988, April 1, 2002]	11897567
Suzanne M. de la Monte		University School of Medicine, Providence, Rhode Island	delamonte@hotmail.com	401-444-7364	401-444-2939	The AD7C-NTP neuronal thread protein biomarker for detecting Alzheimer's disease	[Frontiers in Bioscience 7, d989-996, April 1, 2002]	11897561
Jack R. Wands		University School of Medicine, Providence, Rhode Island				The AD7C-NTP neuronal thread protein biomarker for detecting Alzheimer's disease	[Frontiers in Bioscience 7, d989-996, April 1, 2002]	11897561
Mikio Shoji		Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama, 700-8558 Japan	mshoji@cc.okayama-u.ac.jp	+81-86-235-7365	+81-86-235-7368	Cerebrospinal fluid Ab40 and Ab42: natural course and clinical usefulness	[Frontiers in Bioscience 7, d997-1006, April 1, 2002]	11897565
Gary E. Gibson		Weill Medical College of Cornell University at Burke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, NY 10605	ggibson@med.cornell.edu	914-5597-2291	914-597-2757	Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease	[Frontiers in Bioscience 7, d1007-1015, April 1, 2002]	11897553
Hsueh-Meei Huang		Weill Medical College of Cornell University at Burke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, NY 10605				Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease	[Frontiers in Bioscience 7, d1007-1015, April 1, 2002]	11897553
Anastazija Gnjec		University of Western Australia				Transition metal chelator therapy - a potential treatment for Alzheimer's disease?	[Frontiers in Bioscience 7, d1016-1023, April 1, 2002]	11897554
Justin A Fonte		University of Western Australia				Transition metal chelator therapy - a potential treatment for Alzheimer's disease?	[Frontiers in Bioscience 7, d1016-1023, April 1, 2002]	11897554
Craig Atwood		Case Western Reserve University, Clevleand, OH 44106				Transition metal chelator therapy - a potential treatment for Alzheimer's disease?	[Frontiers in Bioscience 7, d1016-1023, April 1, 2002]	11897554
Ralph N. Martins		University of Western Australia	rmartins@cyllene.uwa.edu.au	+61-08-9346 6656	+61 8 9346 6666	Transition metal chelator therapy - a potential treatment for Alzheimer's disease?	[Frontiers in Bioscience 7, d1016-1023, April 1, 2002]	11897554
James E. Cleaver,		University of California, San Francisco, CA. 94143-0808	jcleaver@cc.ucsf.edu	415-476-4563	415-476-8218	UV damage, DNA repair and skin carcinogenesis	[Frontiers in Bioscience 7, d1024-1043, April 1, 2002]	11897551
Eileen Crowley		University of California, San Francisco, CA. 94143-0808				UV damage, DNA repair and skin carcinogenesis	[Frontiers in Bioscience 7, d1024-1043, April 1, 2002]	11897551
Homer S. Black		Veterans Affairs Medical Center and Department of Dermatology, Baylor College of Medicine, Houston, Texas, 77030	hblack@bcm.tmc.edu	713-794-7637	713-794-7638	Pro-oxidant and anti-oxidant mechanism(s) of BHT and b-carotene in photocarcinogenesis	[Frontiers in Bioscience 7, d1044-1055, April 1, 2002]	11897548
Graham Pawelec		University of Tübingen, Center for Medical Research, ZMF, Waldhörnlestr. 22, D-72072 Tübingen, Germany	graham.pawelec@uni-tuebingen.de	+49 7071 298 2805	+49 7071 295567	T cells and aging, january 2002 update	[Frontiers in Bioscience 7, d1056-1183, May 1, 2002]	11991846
Yvonne Barnett		University of Ulster, Coleraine, UK				T cells and aging, january 2002 update	[Frontiers in Bioscience 7, d1056-1183, May 1, 2002]	11991846
Ros Forsey		Unilever Research, Bedford, UK				T cells and aging, january 2002 update	[Frontiers in Bioscience 7, d1056-1183, May 1, 2002]	11991846
Yasuo Ogawa		Juntendo University, Tokyo, Japan	ysogawa@med.juntendo.ac.jp	+81-3-5802-1034	+81-3-5802-0419	Ryanodine receptor isoforms of non-mammalian skeletal muscle	[Frontiers in Bioscience 7, d1184-1194, May 1, 2002]	11991845
Takashi Murayama		Juntendo University, Tokyo, Japan				Ryanodine receptor isoforms of non-mammalian skeletal muscle	[Frontiers in Bioscience 7, d1184-1194, May 1, 2002]	11991845
Nagomi Kurebayashi		Juntendo University, Tokyo, Japan				Ryanodine receptor isoforms of non-mammalian skeletal muscle	[Frontiers in Bioscience 7, d1184-1194, May 1, 2002]	11991845
Eduardo Ríos		Rush University, 1750 W. Harrison Street, Chicago, IL 60612	erios@rush.edu	312-942-2081	312-942-8711	CA2+ release flux underlying CA2+ transients and CA2+ sparks in skeletal muscle	[Frontiers in Bioscience 7, d1195-1211, May 1, 2002]	11991852
Gustavo Brum		Facultad de Medicina, Universidad de la República, G. Flores 2125, Montevideo, Uruguay				CA2+ release flux underlying CA2+ transients and CA2+ sparks in skeletal muscle	[Frontiers in Bioscience 7, d1195-1211, May 1, 2002]	11991852
Martin F. Schneider		University of Maryland School of Medicine, 108 N. Greene St, Baltimore, MD 21201	mschneid@umaryland.edu	410-706-7812	410-706-8297	Initiation and termination of calcium sparks in skeletal muscle	[Frontiers in Bioscience 7, d1212-1222, May 1, 2002]	11991852
Christopher W. Ward		University of Maryland School of Medicine, 108 N. Greene St, Baltimore, MD 21201				Initiation and termination of calcium sparks in skeletal muscle	[Frontiers in Bioscience 7, d1212-1222, May 1, 2002]	11991854
Alan J. Williams		Imperial College of Science, Technology & Medicine, Dovehouse St., London SW3 6LY, United Kingdom	a.j.williams@ic.ac.uk	+44 020 7351 8137	+44 020 7823 3392	Ion conduction and selectivity in the ryanodine receptor channel	[Frontiers in Bioscience 7, d1223-1230, May 1, 2002]	11991860
Siamak Tabibzadeh		Stony Brook University, Stony Brook, NY 11794	Tabibzadeh@bioscience.org	516-484-2831	516-484-2831	Homeostasis of extracellular matrix by TGF-beta and lefty	[Frontiers in Bioscience 7, d1231-1246, May 1, 2002]	11991857
Allison M. Hanlon		Temple University School of Medicine, Philadelphia PA 19140				Signaling from cytokine receptors that affect TH1 responses	[Frontiers in Bioscience 7, d1247-1254, May 1, 2002]	11991837
Sihyug Jang		Temple University School of Medicine, Philadelphia PA 19140				Signaling from cytokine receptors that affect TH1 responses	[Frontiers in Bioscience 7, d1247-1254, May 1, 2002]	11991837
Padmini Salgame		Temple University School of Medicine, Philadelphia PA 19140	salgame@temple.edu	215-707-4260	215-70- 7788	Signaling from cytokine receptors that affect TH1 responses	[Frontiers in Bioscience 7, d1247-1254, May 1, 2002]	11991837
Stanley A. Thayer		University of Minnesota, 6-120 Jackson Hall, 321 Church Street, SE, Minneapolis, MN 55455-0217				Modulating CA2+ clearance from neurons	[Frontiers in Bioscience 7, d1255-1279, May 1, 2002]	11991858
Yuriy M. Usachev		University of Minnesota, 6-120 Jackson Hall, 321 Church Street, SE, Minneapolis, MN 55455-0217	thayer@med.umn.edu	612-626-7049	612-625-8408	Modulating CA2+ clearance from neurons	[Frontiers in Bioscience 7, d1255-1279, May 1, 2002]	11991858
William J. Pottorf		University of Minnesota, 6-120 Jackson Hall, 321 Church Street, SE, Minneapolis, MN 55455-0217				Modulating CA2+ clearance from neurons	[Frontiers in Bioscience 7, d1255-1279, May 1, 2002]	11991858
Christoph Knosalla		Massachusetts General Hospital/Harvard Medical School, Boston, USA				[Frontiers in Bioscience 7, d1280-1287, May 1, 2002]	Xenotransplantation and tolerance	11991841
David K.C. Cooper		Massachusetts General Hospital/Harvard Medical School, Boston, USA	David.Cooper@tbrc.mgh.harvard.edu	617-724-8313	617-726-4067	[Frontiers in Bioscience 7, d1280-1287, May 1, 2002]	Xenotransplantation and tolerance	11991841
Ernst Niggli,		University of Bern, Bühlplatz 5, 3012 Bern, Switzerland	niggli@pyl.unibe.ch	+41 31 631 8730	+41 31 631 4611	Calcium quarks	[Frontiers in Bioscience 7, d1288-1297, May 1, 2002]	11991844
Marcel Egger		University of Bern, Bühlplatz 5, 3012 Bern, Switzerland				Calcium quarks	[Frontiers in Bioscience 7, d1288-1297, May 1, 2002]	11991844
Nathalie C. Franc		University College London, Gower street, London WC1E 6BT, United Kingdom	n.franc@ucl.ac.uk	+44020-7679-7255	+44020-7679-7805	Phagocytosis of apoptotic cells in mammals, Caenorhabditis Elegans and drosophila Melanogaster: molecular mechanisms and physiological consequences	[Frontiers in Bioscience 7, d1298-1313, May 1, 2002]	11991836
Ping Zhang		Louisiana State University Health Sciences Center, New Orleans, LA 70112				Pulmonary host defenses and alcohol	[Frontiers in Bioscience 7, d1314-1330, May 1, 2002]	11991862
Gregory J. Bagby		Louisiana State University Health Sciences Center, New Orleans, LA 70112				Pulmonary host defenses and alcohol	[Frontiers in Bioscience 7, d1314-1330, May 1, 2002]	11991862
Kyle I. Happel		Louisiana State University Health Sciences Center, New Orleans, LA 70112				Pulmonary host defenses and alcohol	[Frontiers in Bioscience 7, d1314-1330, May 1, 2002]	11991862
Warren R. Summer		Louisiana State University Health Sciences Center, New Orleans, LA 70112				Pulmonary host defenses and alcohol	[Frontiers in Bioscience 7, d1314-1330, May 1, 2002]	11991862
Steve Nelson		Louisiana State University Health Sciences Center, New Orleans, LA 70112	snelsol@lsuhsc.edu	504-568-4634	504-568-4295	Pulmonary host defenses and alcohol	[Frontiers in Bioscience 7, d1314-1330, May 1, 2002]	11991862
Jessamyn Bagley		Massachusetts General Hospital and Harvard Medical School, 149-5210 13th St., Boston, MA 02129				Establishing immunological tolerance through the induction of molecular chimerism	[Frontiers in Bioscience 7, d1331-1337, May 1, 2002]	11991829
Jennifer L. Bracy		Massachusetts General Hospital and Harvard Medical School, 149-5210 13th St., Boston, MA 02129				Establishing immunological tolerance through the induction of molecular chimerism	[Frontiers in Bioscience 7, d1331-1337, May 1, 2002]	11991829
Chaouri Tian		Massachusetts General Hospital and Harvard Medical School, 149-5210 13th St., Boston, MA 02129				Establishing immunological tolerance through the induction of molecular chimerism	[Frontiers in Bioscience 7, d1331-1337, May 1, 2002]	11991829
Eun-Suk Kang		Massachusetts General Hospital and Harvard Medical School, 149-5210 13th St., Boston, MA 02129				Establishing immunological tolerance through the induction of molecular chimerism	[Frontiers in Bioscience 7, d1331-1337, May 1, 2002]	11991829
John Iacomini		Massachusetts General Hospital and Harvard Medical School, 149-5210 13th St., Boston, MA 02129	john.iacomini@tbrc.mgh.harvard.edu	617-724-9846	617-724-9218	Establishing immunological tolerance through the induction of molecular chimerism	[Frontiers in Bioscience 7, d1331-1337, May 1, 2002]	11991829
Daniel R. Brown		College of Veterinary Medicine, University of Florida, Gainesville, Florida	brownd@mail.vetmed.ufl.edu	+1-352-392-4700X3975	+1-352-392-9704	Mycoplasmosis and immunity of fish and reptiles	[Frontiers in Bioscience 7, d1338-1346, May 1, 2002]	11991833
Judy M. Hickman-Davis		University of Alabama at Birmingham, Department of Anesthesiology, Birmingham, AL	Judy.Hickman-Davis@ccc.uab.edu	205-934-7010	205-934-7437	Role of innate immunity in respiratory mycoplasma infection	[Frontiers in Bioscience 7, d1347-1355, May 1, 2002]	11991835
Claus W. Heizmann,		University of Zürich, Steinwiesstrasse 75, CH- 8032 Zürich, Switzerland	Claus.Heizmann@kispi.unizh.ch	+41 1 266 7541	+41 1 266 7169	S100 proteins: structure, functions and pathology	[Frontiers in Bioscience 7, d1356-1368, May 1, 2002]	11991838
Günter Fritz		University of Zürich, Steinwiesstrasse 75, CH- 8032 Zürich, Switzerland				S100 proteins: structure, functions and pathology	[Frontiers in Bioscience 7, d1356-1368, May 1, 2002]	11991838
Beat W. Schäfer		University of Zürich, Steinwiesstrasse 75, CH- 8032 Zürich, Switzerland				S100 proteins: structure, functions and pathology	[Frontiers in Bioscience 7, d1356-1368, May 1, 2002]	11991838
Haggit Ben-Israel		Technion - Israel Institute of Technology, Haifa 31096, Israel				Adenovirus and cell cycle control	[Frontiers in Bioscience 7, d1369-1395, May 1, 2002]	11991831
Tamar Kleinberger		Technion - Israel Institute of Technology, Haifa 31096, Israel	tamark@tx.technion.ac.il	972-4-829-5257	972-4-829-5225	Adenovirus and cell cycle control	[Frontiers in Bioscience 7, d1369-1395, May 1, 2002]	11991831
Barry J. Potter		Louisiana State University Health Sciences Center, New Orleans, Louisiana	bpotte@lsuhsc.edu	504-568-3385	504-568-6158	Molecular regulation of iron homeostasis and resistance to infection in alcoholics	[Frontiers in Bioscience 7, d1396-1409, May 1, 2002]	11991850
Feng Wang		Louisiana State University Health Sciences Center, New Orleans, Louisiana				Molecular regulation of iron homeostasis and resistance to infection in alcoholics	[Frontiers in Bioscience 7, d1396-1409, May 1, 2002]	11991850
F. Chris Minion		Iowa State University, Ames, IA 50011	fcminion@iastate.edu	515-294-6347	515-294-8500	mycoplasma animal respiratory pathogens	[Frontiers in Bioscience 7, d1410-1422, June 1, 2002]	12045010
Joshua Daniel Nosanchuk		Albert Einstein College of Medicine, Bronx, NY	nosanchu@aecom.yu.edu	718-430-3766	718-430-8701	Fungal myocarditis	[Frontiers in Bioscience 7, d1423-1438, June 1, 2002]	12045009
William T. Penberthy		UCLA, 621 Charles E. Young Dr. South, Los Angeles, CA 90095-1606				The zebrafish as a model for human disease	[Frontiers in Bioscience 7, d1439-1453, June 1, 2002]	12045008
Ebrahim Shafizadeh		UCLA, 621 Charles E. Young Dr. South, Los Angeles, CA 90095-1606				The zebrafish as a model for human disease	[Frontiers in Bioscience 7, d1439-1453, June 1, 2002]	12045008
Shuo Lin		UCLA, 621 Charles E. Young Dr. South, Los Angeles, CA 90095-1606	shuolin@ucla.edu	310-267-4970	310-206-9184	The zebrafish as a model for human disease	[Frontiers in Bioscience 7, d1439-1453, June 1, 2002]	12045008
Sandor Györke		Texas Tech University Health Sciences Center, Lubbock, Texas 79430-6551	sandor.gyorke@ttuhsc.edu	806-743-2520	806-743-1512	Regulation of sarcoplasmic reticulum calcium release by luminal calcium in cardiac muscle	[Frontiers in Bioscience 7, d1454-1463, June 1, 2002]	12045014
Inna Györke		Texas Tech University Health Sciences Center, Lubbock, Texas 79430-6551				Regulation of sarcoplasmic reticulum calcium release by luminal calcium in cardiac muscle	[Frontiers in Bioscience 7, d1454-1463, June 1, 2002]	12045014
Valeriy Lukyanenko		Texas Tech University Health Sciences Center, Lubbock, Texas 79430-6551				Regulation of sarcoplasmic reticulum calcium release by luminal calcium in cardiac muscle	[Frontiers in Bioscience 7, d1454-1463, June 1, 2002]	12045014
Dmitriy Terentyev		Texas Tech University Health Sciences Center, Lubbock, Texas 79430-6551				Regulation of sarcoplasmic reticulum calcium release by luminal calcium in cardiac muscle	[Frontiers in Bioscience 7, d1454-1463, June 1, 2002]	12045014
Serge Viatchenko-Karpinski		Texas Tech University Health Sciences Center, Lubbock, Texas 79430-6551				Regulation of sarcoplasmic reticulum calcium release by luminal calcium in cardiac muscle	[Frontiers in Bioscience 7, d1454-1463, June 1, 2002]	12045014
Theodore F. Wiesner		Texas Tech University Health Sciences Center, Lubbock, Texas 79430-6551				Regulation of sarcoplasmic reticulum calcium release by luminal calcium in cardiac muscle	[Frontiers in Bioscience 7, d1454-1463, June 1, 2002]	12045014
Terence Wagenknecht		Department of Health, Albany, NY 12201	tcw02@wcnotes.wadsworth.org	518-474-2450	518-474-7992	Three-dimensional reconstruction of ryanodine receptors	[Frontiers in Bioscience 7, d1464-1474, June 1, 2002]	12045016
Montserrat Samsó		Department of Health, Albany, NY 12201				Three-dimensional reconstruction of ryanodine receptors	[Frontiers in Bioscience 7, d1464-1474, June 1, 2002]	12045016
Siamak Tabibzadeh		Stony Brook University, Stony Brook, NY 11794	tabibzadeh@bioscience.org	516-484-2831	516-484-2831	Decoding implantation and menstruation: the tale of two opposing signals	[Frontiers in Bioscience 7, d1475-1486, June 1, 2002]	12045020
Thomas R. Jerrells		University of Nebraska Medical Center and Omaha VA Medical Center, Omaha, NE 68105, USA	tjerrell@unmc.edu	+1-402-346-8800 Ext. 3361	+1-402-449-0604	Association of alcohol consumption and exaggerated immunopathologic effects in the liver induced by infectious organism	[Frontiers in Bioscience 7, d1487-1493, June 1, 2002]	12045012
Illya Tietzel		University of Maryland, College Park, MD 20742				The modulation of macrophage activation by tyrosine phosphorylation	[Frontiers in Bioscience 7, d1494-1502, June 1, 2002]	12045018
David M. Mosser		University of Maryland, College Park, MD 20742	dm268@umail.umd.edu	301-314-2594	301-314-9489	The modulation of macrophage activation by tyrosine phosphorylation	[Frontiers in Bioscience 7, d1494-1502, June 1, 2002]	12045018
Mark J. Newman		Epimmune Inc., 5820 Nancy Ridge Drive, San Diego, CA 92121	mnewman@epimmune.com	858-860-2500	858-860-2600	T-lymphocyte epitope identification and their use in vaccine development for HIV-1	[Frontiers in Bioscience 7, d1503-1515, June 1, 2002]	12048179
Brian Livingston		Epimmune Inc., 5820 Nancy Ridge Drive, San Diego, CA 92121				T-lymphocyte epitope identification and their use in vaccine development for HIV-1	[Frontiers in Bioscience 7, d1503-1515, June 1, 2002]	12048179
Denise M. McKinney		Epimmune Inc., 5820 Nancy Ridge Drive, San Diego, CA 92121				T-lymphocyte epitope identification and their use in vaccine development for HIV-1	[Frontiers in Bioscience 7, d1503-1515, June 1, 2002]	12048179
Robert W. Chesnut		Epimmune Inc., 5820 Nancy Ridge Drive, San Diego, CA 92121				T-lymphocyte epitope identification and their use in vaccine development for HIV-1	[Frontiers in Bioscience 7, d1503-1515, June 1, 2002]	12048179
Alessandro Sette		Epimmune Inc., 5820 Nancy Ridge Drive, San Diego, CA 92121				T-lymphocyte epitope identification and their use in vaccine development for HIV-1	[Frontiers in Bioscience 7, d1503-1515, June 1, 2002]	12048179
Olga Greco		University of Naples "Federico II", Naples 80126, Italy	Olga.Greco@na.infn.it	++39 081676220	++39 081 667625	Cancer gene therapy: 'delivery, delivery, delivery'	[Frontiers in Bioscience 7, d1516-1524, June 1, 2002]	12045003
Simon D. Scott		Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201				Cancer gene therapy: 'delivery, delivery, delivery'	[Frontiers in Bioscience 7, d1516-1524, June 1, 2002]	12045003
Brian Marples		Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201				Cancer gene therapy: 'delivery, delivery, delivery'	[Frontiers in Bioscience 7, d1516-1524, June 1, 2002]	12045003
And Gabi U. Dachs		Tumour Microcirculation Group, Gray Cancer Institute, PO BOX 100, HA6 2JR Northwood, UK				Cancer gene therapy: 'delivery, delivery, deliverys'	[Frontiers in Bioscience 7, d1516-1524, June 1, 2002]	12045003
Frank R. de Gruijl		Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands	F.R.de_Gruijl@lumc.nl	++31 71 5271902	++31 71 5271910	Physical variables in experimental photocarcinogenesis and quantitative relationships between stages of tumor development	[Frontiers in Bioscience 7, d1525-1530, June 1, 2002]	12045015
Jan C. van der Leun		EcoFys, PO Box 8408, NL-3503 RK Utrecht, Netherlands				Physical variables in experimental photocarcinogenesis and quantitative relationships between stages of tumor development	[Frontiers in Bioscience 7, d1525-1530, June 1, 2002]	12045015
Ronald D. Ley		University of New Mexico Health Sciences Center, Albuquerque, NM	rley@unm.edu	505-272-5142	505-272-9105	Animal models of ultraviolet radiation (uvr)-induced cutaneous melanoma	[Frontiers in Bioscience 7, d1531-1534, June 1, 2002]	12045011
Daniel D. Carson		University of Delaware, Newark, DE 19707	dcarson@udel.edu	302-831-6977	302-831-1033	The glycobiology of implantation	[Frontiers in Bioscience 7, d1535-1544, June 1, 2002]	12045005
Virginia Rider		Pittsburg State University, 1701 South Broadway, Pittsburg, Kansas 66762	vrider@pittstate.edu	620-235-4739	620-235-4194	Progesterone and the control of uterine cell proliferation and differentiation	[Frontiers in Bioscience 7, d1545-1555, June 1, 2002]	12045023
Rosalia C.M. Simmen		University of Arkansas for Medical Sciences, Little Rock, Arkansas 72202	simmenrosalia@uams.edu	501-320-2859	501-320-3161	Progesterone receptors and Sp/Krüppel-like family members in the uterine endometrium	[Frontiers in Bioscience 7, d1556-1565, June 1, 2002]	12045021
Frank A. Simmen		University of Arkansas for Medical Sciences, Little Rock, Arkansas 72202				Progesterone receptors and Sp/Krüppel-like family members in the uterine endometrium	[Frontiers in Bioscience 7, d1556-1565, June 1, 2002]	12045021
Linda Tseng		State University of New York at Stony Brook, Stony Brook, New York, 11794	litseng@notes.cc.sunysb.edu	631-444-2742	631-444-7740	Endometrial cell specific gene activation during implantation and early pregnancy	[Frontiers in Bioscience 7, d1566-1574, June 1, 2002]
James Mazella		State University of New York at Stony Brook, Stony Brook, New York, 11794	litseng@notes.cc.sunysb.edu	631-444-2742	631-444-7740	Endometrial cell specific gene activation during implantation and early pregnancy	[Frontiers in Bioscience 7, d1566-1574, June 1, 2002]	12045017
Michael A. Jarvis		Oregon Health Sciences University, Portland, Oregon 97201				Mechanisms of human cytomegalovirus persistence and latency	[Frontiers in Bioscience 7, d1575-1582, June 1, 2002]	12045013
Jay A. Nelson		Oregon Health Sciences University, Portland, Oregon 97201	nelsonj@ohsu.edu	503-494-7768	503-494-6862	Mechanisms of human cytomegalovirus persistence and latency	[Frontiers in Bioscience 7, d1575-1582, June 1, 2002]	12045013
Wei Tang		Baylor College of Medicine, Houston, Texas				Calmodulin modulation of proteins involved in excitation-contraction coupling	[Frontiers in Bioscience 7, d1583-1589, June 1, 2002]	12045019
Serap Sencer		Baylor College of Medicine, Houston, Texas				Calmodulin modulation of proteins involved in excitation-contraction coupling	[Frontiers in Bioscience 7, d1583-1589, June 1, 2002]	12045019
Susan L. Hamilton		Baylor College of Medicine, Houston, Texas	susanh@bcm.tmc.edu	713-798-5704	713-798-5441	Calmodulin modulation of proteins involved in excitation-contraction coupling	[Frontiers in Bioscience 7, d1583-1589, June 1, 2002]	12045019
Salvatore Florio		University of Naples "Federico II" Naples Italy	florio@unina.it	+39-081-5644206	+39-081-5644230	GnRH and steroids in cancer	[Frontiers in Bioscience 7, d1590-1608, June 1, 2002]	12045004
Ugo Pagnini		University of Naples "Federico II" Naples Italy				GnRH and steroids in cancer	[Frontiers in Bioscience 7, d1590-1608, June 1, 2002]	12045004
Antonio Crispino		University of Naples "Federico II" Naples Italy				GnRH and steroids in cancer	[Frontiers in Bioscience 7, d1590-1608, June 1, 2002]	12045004
Carmen Pacilio		University of Naples "Federico II" Naples Italy				GnRH and steroids in cancer	[Frontiers in Bioscience 7, d1590-1608, June 1, 2002]	12045004
Luca Crispino		University of Naples "Federico II" Naples Italy				GnRH and steroids in cancer	[Frontiers in Bioscience 7, d1590-1608, June 1, 2002]	12045004
Antonio Giordano		Sbarro Institute for Cancer Research and Molecular Medicine. College of Science and Technology, Temple University, 1900 N 12th Street, Philadelphia, PA 19122				GnRH and steroids in cancer	[Frontiers in Bioscience 7, d1590-1608, June 1, 2002]	12045004
Carl T. D'Angio		University of Rochester School of Medicine and Dentistry, Rochester NY	carl_dangio@urmc.rochester.edu	585-273-4911	585-461-3614	The role of vascular growth factors in hyperoxia-induced injury to the developing lung	[Frontiers in Bioscience 7, d1609-1623, July 1, 2002]	12086914
William M. Maniscalco		University of Rochester School of Medicine and Dentistry, Rochester NY				The role of vascular growth factors in hyperoxia-induced injury to the developing lung	[Frontiers in Bioscience 7, d1609-1623, July 1, 2002]	12086914
Vineet Bhandari		Yale University School of Medicine, New Haven, CT.	vineet.bhandari@yale.edu	203-688-2320	203-688-5426	Developmental differences in the role of interleukins in hyperoxic lung injury in animal models	[Frontiers in Bioscience 7, d1624-1633, July 1, 2002]	12086923
Xian-Cheng Jiang		SUNY Downstate Medical Center, Brooklyn, NY 11203	xjiang@downstate.edu	718-270-6701	718-270-3732	The effect of phospholipid transfer protein on lipoprotein metabolism and atherosclerosis	[Frontiers in Bioscience 7, d1634-1641, July 1, 2002]	12086920
Hiroshi Takeshima		Tohoku University Graduate School of Medicine, Seiryo-machi, Aoba-ku, Miyagi 980-8575, Japan	takeshim@mail.cc.tohoku.ac.jp	+81-22-717-8084	+81-22-717-8090	Intracellular Ca²⁺store in embryonic cardiac myocytes	[Frontiers in Bioscience 7, d1642-1652, July 1, 2002]	12086916
Page Baluch		Arizona State University, Tempe, Arizona 85287-1501				Cellular scaffolds in mammalian eggs	[Frontiers in Bioscience 7, d1653-1661, July 1, 2002]	12086913
David G. Capco		Arizona State University, Tempe, Arizona 85287-1501	dcapco@asu.edu	480-965-7011	480-965-2519	Cellular scaffolds in mammalian eggs	[Frontiers in Bioscience 7, d1653-1661, July 1, 2002]	12086913
Robert G Batey		John Hunter Hospital, Newcastle 2310, NSW Australia				Molecular pathogenesis of T lymphocyte-induced liver injury in alcoholic hepatitis	[Frontiers in Bioscience 7, d1662-1675, July 1, 2002]	12086911
Jianhua Wang		John Hunter Hospital, Newcastle 2310, NSW Australia	rbatey@hunter.health.nsw.gov.au	61 2 49213540	61 2 49213537	Molecular pathogenesis of T lymphocyte-induced liver injury in alcoholic hepatitis	[Frontiers in Bioscience 7, d1662-1675, July 1, 2002]	12086911
Agustín Guerrero-Hernández		CINVESTAV-IPN, México D.F. 07000	aguerrer@mail.cinvestav.mx	52-55-5747-7000 ext 5210	52-55-5747-7083	Ryanodine receptors in smooth muscle	[Frontiers in Bioscience 7, d1676-1688, July 1, 2002]	12086921
Leticia Gómez-Viquez		CINVESTAV-IPN, México D.F. 07000				Ryanodine receptors in smooth muscle	[Frontiers in Bioscience 7, d1676-1688, July 1, 2002]	12086921
Guadalupe Guerrero-Serna		CINVESTAV-IPN, México D.F. 07000				Ryanodine receptors in smooth muscle	[Frontiers in Bioscience 7, d1676-1688, July 1, 2002]	12086921
Angélica Rueda		CINVESTAV-IPN, México D.F. 07000				Ryanodine receptors in smooth muscle	[Frontiers in Bioscience 7, d1676-1688, July 1, 2002]	12086921
Shirish S. Barve		University of Louisville Medical Center , Louisville, KY 40202	shirish.barve@louisville.edu	502-852-5244/45	502-852-0846	Mechanisms of alcohol-mediated CD⁴⁺T lymphocyte death: relevance to HIV and HCV pathogenesis	[Frontiers in Bioscience 7, d1689-1696, July 1, 2002]	12086912
Sujata V. Kelkar		University of Louisville Medical Center , Louisville, KY 40202				Mechanisms of alcohol-mediated CD⁴⁺T lymphocyte death: relevance to HIV and HCV pathogenesis	[Frontiers in Bioscience 7, d1689-1696, July 1, 2002]	12086912
Leila Gobejishvilli		University of Louisville Medical Center , Louisville, KY 40202				Mechanisms of alcohol-mediated CD⁴⁺T lymphocyte death: relevance to HIV and HCV pathogenesis	[Frontiers in Bioscience 7, d1689-1696, July 1, 2002]	12086912
Swati Joshi-Barve		University of Louisville Medical Center , Louisville, KY 40202				Mechanisms of alcohol-mediated CD⁴⁺T lymphocyte death: relevance to HIV and HCV pathogenesis	[Frontiers in Bioscience 7, d1689-1696, July 1, 2002]	12086912
Craig J. McClain		University of Louisville Medical Center , Louisville, KY 40202				Mechanisms of alcohol-mediated CD⁴⁺T lymphocyte death: relevance to HIV and HCV pathogenesis	[Frontiers in Bioscience 7, d1689-1696, July 1, 2002]	12086912
Donald M. Bers		Loyola University Chicago, Stritch School of Medicine, Maywood, IL	dbers@lumc.edu	708-216-1018	708-216-6308	Sarcoplasmic reticulum Ca release in intact ventricular myocytes	[Frontiers in Bioscience 7, d1697-1711, July 1, 2002]	12086924
Shiuan Chen		Beckman Research Institute of the City of Hope, Duarte, CA 91010	schen@coh.org	626-359-8111 ext. 62601	. 626-301-8186	Modulation of aromatase activity and expression by environmental chemicals	[Frontiers in Bioscience 7, d1712-1719, August 1, 2002]	12133813
Massimo Pinzani		Università degli Studi di Firenze, Firenze, Italy	m.pinzani@dmi.unifi.it	+39-055-4296473	+39-055-417123	PDGF and signal transduction in hepatic stellate cells	[Frontiers in Bioscience 7, d1720-1726, August 1, 2002]	12133817
William Welch		University of Nevada, Reno, Nevada	welch@unr.nevada.edu	312-765-3232	312-765-3233	Quantitative relationships between ryanoids, receptor affinity and channel conductance	[Frontiers in Bioscience 7, d1727-1742, August 1, 2002]	12133825
Annie Pardo		Universidad Nacional Autónoma de México. Apartado Postal 21-630. Coyoacan; México DF, 04000; México				Molecular mechanisms of pulmonary fibrosis	[Frontiers in Bioscience 7, d1743-1761, August 1, 2002]	12133818
Moisés Selman		Instituto Nacional de Enfermedades Respiratorias, Tlalpan 4502; México DF, 14080; México	mselman@sni.conacyt.mx	525-665-0043	525-665-4623	Molecular mechanisms of pulmonary fibrosis	[Frontiers in Bioscience 7, d1743-1761, August 1, 2002]	12133818
J. Dennis Pollack		Ohio State University, 333 West 10^th Avenue, Columbus, OH 43210	pollack.1@osu.edu	614-457-9763	614-457-7865	The necessity of combining genomic and enzymatic data to infer metabolic function and pathways in the smallest bacteria: amino acid, purine and pyrimidine metabolism in mollicutes	[Frontiers in Bioscience 7, d1762-1781, August 1, 2002]	12133816
Irwin H. Gelman		Mount Sinai School of Medicine, New York, NY	irwin.gelman@mssm.edu	212-241-3749	212-828-4202	The role of SSeCKS/Gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development	[Frontiers in Bioscience 7, d1782-1797, August 1, 2002]	12133808
Jean-Pierre Claverys		CNRS-Université Paul Sabatier, 118 route de Narbonne, 31062 Toulouse Cedex, France				Extracellular-peptide control of competence for genetic transformation in Streptococcus Pneumoniae	[Frontiers in Bioscience 7, d1798-1814, August 1, 2002]	12133809
Leiv Sigve Havarstein		Agricultural University of Norway, PO Box 5040, N-1432, As, Norway	sigve.havarstein@ikb.nlh.no	47-64949464	47-64947720	Extracellular-peptide control of competence for genetic transformation in Streptococcus Pneumoniae	[Frontiers in Bioscience 7, d1798-1814, August 1, 2002]	12133809
Mitsuo Ogura		Tokai University, Orido 3-20-1, Shimizu, Shizuoka 424-8610, Japan				Recent progress in Bacillus subtilis two-component regulation	[Frontiers in Bioscience 7, d1815-1824, August 1, 2002]	12133819
Teruo Tanaka		Tokai University, Orido 3-20-1, Shimizu, Shizuoka 424-8610, Japan	teruot@scc.u-tokai.ac.jp	543-34-0411 ex 2933	543-34-9834	Recent progress in Bacillus subtilis two-component regulation	[Frontiers in Bioscience 7, d1815-1824, August 1, 2002]	12133819
Ambrose L Cheung		Dartmouth Medical School, Hanover, NH	ambrose.cheung@dartmouth.edu	603-650-1340	603-650-1362	Global regulation of virulence determinants in Staphylococcus Aureus by the SarA protein family	[Frontiers in Bioscience 7, d1825-1842, August 1, 2002]	12133812
Gongyi Zhang		University of Colorado Medical School, Denver, CO 80286				Global regulation of virulence determinants in Staphylococcus Aureus by the SarA protein family	[Frontiers in Bioscience 7, d1825-1842, August 1, 2002]	12133812
Joanna R. Klein		University of Minnesota Medical School, 1460 Mayo Bldg/Box 196, 420 Delaware St. SE, Minneapolis, MN, 55455-0312				Bacterial group II introns and their association with mobile genetic elements	[Frontiers in Bioscience 7, d1843-1856, August 1, 2002]	12133822
Gary M. Dunny		University of Minnesota Medical School, 1460 Mayo Bldg/Box 196, 420 Delaware St. SE, Minneapolis, MN, 55455-0312	gary-d@biosci.cbs.umn.edu	612-625-9930	612-626-0623	Bacterial group II introns and their association with mobile genetic elements	[Frontiers in Bioscience 7, d1843-1856, August 1, 2002]	12133822
Peter Zuber		Oregon Health & Science University, Beaverton, OR 97006	pzuber@bmb.ogi.edu	503-748-7335	503-748-1464	Control of gene expression in gram-positive bacteria: extensions of and departures from enteric paradigms	[Frontiers in Bioscience 7, d1857-1866, August 1, 2002]	12133824
Heping Cheng		National Institutes of Health, Baltimore, Maryland	chengp@grc.nia.nih.gov	410-558-8634	410-558-8150	Calcium signaling between sarcolemmal calcium channels and ryanodine receptors in heart cells	[Frontiers in Bioscience 7, d1867-1878, September 1, 2002]	12161336
Shi-Qiang Wang		National Institutes of Health, Baltimore, Maryland				Calcium signaling between sarcolemmal calcium channels and ryanodine receptors in heart cells	[Frontiers in Bioscience 7, d1867-1878, September 1, 2002]	12161336
Thomas E. Spencer		Texas A&M University, College Station, Texas 77843-2471	fbazer@cvm.tamu.edu	979-845-5929	979-862-2662	Biology of progesterone action during pregnancy recognition and maintenance of pregnancy	[Frontiers in Bioscience 7, d1879-1898, September 1, 2002]	12161340
Fuller W. Bazer		Texas A&M University, College Station, Texas 77843-2471				Biology of progesterone action during pregnancy recognition and maintenance of pregnancy	[Frontiers in Bioscience 7, d1879-1898, September 1, 2002]	12161340
Fabio Marra		University of Florence, Italy	f.marra@dmi.unifi.it	+39 055 4295475	+39 055 417123	Chemokines in liver inflammation and fibrosis	[Frontiers in Bioscience 7, d1899-1914, September 1, 2002]	12161342
Elliot D. Rosen		University of Notre Dame, Notre Dame, IN 46556	rosen.1@nd.edu	219-631-9365	219-631-8017	Gene targeting in hemostasis. factor X	[Frontiers in Bioscience 7, d1915-1925, September 1, 2002]	12161341
Neil G Anderson		University of Manchester, Oxford Road, Manchester M13 9PT , UK	neil.anderson@man.ac.uk	44-161-275-5496	44-161-275-5600	ErbB receptor tyrosine kinase inhibitors as therapeutic agents	[Frontiers in Bioscience 7, d1926-1940, September 1, 2002]	12161338
Tawhid Ahmad		University of Manchester, Oxford Road, Manchester M13 9PT , UK				ErbB receptor tyrosine kinase inhibitors as therapeutic agents	[Frontiers in Bioscience 7, d1926-1940, September 1, 2002]	12161338
C. Borgeest		University of Maryland, Baltimore, MD 21201				The effects of endocrine disrupting chemicals on the ovary	[Frontiers in Bioscience 7, d1941-1948, September 1, 2002]	12161337
C. Greenfeld		University of Maryland, Baltimore, MD 21201				The effects of endocrine disrupting chemicals on the ovary	[Frontiers in Bioscience 7, d1941-1948, September 1, 2002]	12161337
D. Tomic		University of Maryland, Baltimore, MD 21201				The effects of endocrine disrupting chemicals on the ovary	[Frontiers in Bioscience 7, d1941-1948, September 1, 2002]	12161337
J.A. Flaws		University of Maryland, Baltimore, MD 21201	Jflaws@epi.umaryland.edu	410-706-3606	410-706-1503	The effects of endocrine disrupting chemicals on the ovary	[Frontiers in Bioscience 7, d1941-1948, September 1, 2002]	12161337
John S. Davis		University of Nebraska Medical Center, Omaha, Nebraska 68198-3255				The corpus luteum: an ovarian structure with maternal instincts and suicidal tendencies	[Frontiers in Bioscience 7, d1949-1978, September 1, 2002]	12161347
Bo R. Rueda		Harvard Medical School, Boston, Massachusetts and Vincent Center For Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114	brueda@partners.org	617-724-2825	617-726-0561	The corpus luteum: an ovarian structure with maternal instincts and suicidal tendencies	[Frontiers in Bioscience 7, d1949-1978, September 1, 2002]	12161347
PJ Devine		The University of Arizona, 1501 N. Campbell Ave P.O. Box 245051, Tucson AZ 85724-5051				In vitro ovarian tissue and organ culture: a review	[Frontiers in Bioscience 7, d1979-1989, September 1, 2002]	12161346
KS Rajapaksa		The University of Arizona, 1501 N. Campbell Ave P.O. Box 245051, Tucson AZ 85724-5051				In vitro ovarian tissue and organ culture: a review	[Frontiers in Bioscience 7, d1979-1989, September 1, 2002]	12161346
Patricia B Hoyer		The University of Arizona, 1501 N. Campbell Ave P.O. Box 245051, Tucson AZ 85724-5051	hoyer@u.arizona.edu	520- 626-6688	520-626-2382	In vitro ovarian tissue and organ culture: a review	[Frontiers in Bioscience 7, d1979-1989, September 1, 2002]	12161346
Phillip Kezele		Washington State University, Pullman WA				Cell-cell interactions in primordial follicle assembly and development	[Frontiers in Bioscience 7, d1990-1996, September 1, 2002]	12161345
Eric Nilsson,		Washington State University, Pullman WA				Cell-cell interactions in primordial follicle assembly and development	[Frontiers in Bioscience 7, d1990-1996, September 1, 2002]	12161345
Michael K. Skinner		Washington State University, Pullman WA	Skinner@mail.wsu.edu	509-335-1524	509-335-2176	Cell-cell interactions in primordial follicle assembly and development	[Frontiers in Bioscience 7, d1990-1996, September 1, 2002]	12161345
Jennifer L. Marcinkiewicz,		Kent State University, Kent, OH	jmarcink@kent.edu	330-672-5554	330-672-3713	The involvement of tumor necrosis factor-a (TNF) as an intraovarian regulator of oocyte apoptosis in the neonatal rat	[Frontiers in Bioscience 7, d1997-2005, September 1, 2002]	12161343
Sharon K. Balchak		Kent State University, Kent, OH				The involvement of tumor necrosis factor-a (TNF) as an intraovarian regulator of oocyte apoptosis in the neonatal rat	[Frontiers in Bioscience 7, d1997-2005, September 1, 2002]	12161343
Leisa J. Morrison		Kent State University, Kent, OH				The involvement of tumor necrosis factor-a (TNF) as an intraovarian regulator of oocyte apoptosis in the neonatal rat	[Frontiers in Bioscience 7, d1997-2005, September 1, 2002]	12161343
Barbara Vanderhyden		University of Ottawa, and Ottawa Regional Cancer Centre, Canada	Barbara.Vanderhyden@orcc.on.ca	613-737-7700 ext. 5-6895	613-247-3524	Molecular basis of ovarian development and function	[Frontiers in Bioscience 7, d2006-2022, September 1, 2002]	12161348
David Krizaj		University of California San Francisco School of Medicine, San Francisco, CA 94143-0730	krizaj@phy.ucsf.edu	415-476-3171	415-476-6289	Calcium regulation in photoreceptors	[Frontiers in Bioscience 7, d2023-2044, September 1, 2002]	12161344
David R. Copenhagen		University of California San Francisco School of Medicine, San Francisco, CA 94143-0730				Calcium regulation in photoreceptors	[Frontiers in Bioscience 7, d2023-2044, September 1, 2002]	12161344
Sueharu Horinouchi		The University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan	asuhori@mail.ecc.u-tokyo.ac.jp	81 3 5841 5123	81 3 5841 8021	A microbial hormone, A-factor, as a master switch for morphological differentiation and secondary metabolism in streptomyces griseus	[Frontiers in Bioscience 7, d2045-2057, October 1, 2002]	12165483
Craig D. Woodworth		Clarkson University, Potsdam, NY	woodworth@clarkson.edu	315-268-2391	315-268-7118	HPV innate immunity	[Frontiers in Bioscience 7, d2058-2071, October 1, 2002]	12165480
Gerhard Meissner		University of North Carolina, Chapel Hill, NC 27599-7260	meissner@med.unc.edu	919-966 5021	919-966 2852	Regulation of mammalian ryanodine receptors	[Frontiers in Bioscience 7, d2072-2080, November 1, 2002]	12438018
JianYu Rao		University of California at Los Angeles Medical Center, Los Angeles, CA 90095	jrao@mednet ucla.edu	310-206-1434 310-206-5343	310-794-1567 310-206-5178	Targeting actin remodeling profiles for the detection and management of urothelial cancers - a perspective for bladder cancer research	[Frontiers in Bioscience 7, e1-8, January 1, 2002]	11779712
Ken-ryu Han		University of California School of Medicine, Los Angeles, California, CA 90095				Tumor markers for the early detection of bladder cancer	[Frontiers in Bioscience 7, e19-26, January 1, 2002]	11779696
Allan J Pantuck		University of California School of Medicine, Los Angeles, California, CA 90095				Tumor markers for the early detection of bladder cancer	[Frontiers in Bioscience 7, e19-26, January 1, 2002]	11779696
Arie S Belldegrun		University of California School of Medicine, Los Angeles, California, CA 90095				Tumor markers for the early detection of bladder cancer	[Frontiers in Bioscience 7, e19-26, January 1, 2002]	11779696
Jian-Yu Rao		University of California School of Medicine, Los Angeles, California, CA 90095				Tumor markers for the early detection of bladder cancer	[Frontiers in Bioscience 7, e19-26, January 1, 2002]	11779696
Marek Skacel		The Cleveland Clinic Foundation, Cleveland, OH 44195	mskacel@pol.net	216-444-2200	216-445-6967	Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancer	[Frontiers in Bioscience 7, e27-32, January 1, 2002]	11779714
Louis S. Liou		The Cleveland Clinic Foundation, Cleveland, OH 44195				Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancer	[Frontiers in Bioscience 7, e27-32, January 1, 2002]	11779714
James D. Pettay		The Cleveland Clinic Foundation, Cleveland, OH 44195				Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancer	[Frontiers in Bioscience 7, e27-32, January 1, 2002]	11779714
Raymond R. Tubbs		The Cleveland Clinic Foundation, Cleveland, OH 44195				Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancer	[Frontiers in Bioscience 7, e27-32, January 1, 2002]	11779714
Zhi-Ming Shao		Institute, Fu Dan University, Shanghai, 200032, P. R. China				Angiogenic factors and bladder cancer	[Frontiers in Bioscience 7, e33-35, January 1, 2002]	11779705
Mai Nguyen		UCLA School of Medicine, Los Angeles, CA 90095	mainguyen@mednet.ucla.edu	310-825-7575		Angiogenic factors and bladder cancer	[Frontiers in Bioscience 7, e33-35, January 1, 2002]	11779705
Jennifer D. Sharp		Yale University School of Medicine, New Haven, CT 06520				Bladder cancer detection with urinary survivin, an inhibitor of apoptosis	[Frontiers in Bioscience 7, e36-41, February 1, 2002]	11815300
Derek A. Hausladen		Yale University School of Medicine, New Haven, CT 06520				Bladder cancer detection with urinary survivin, an inhibitor of apoptosis	[Frontiers in Bioscience 7, e36-41, February 1, 2002]	11815300
Grey Maher		Yale University School of Medicine, New Haven, CT 06520				Bladder cancer detection with urinary survivin, an inhibitor of apoptosis	[Frontiers in Bioscience 7, e36-41, February 1, 2002]	11815300
Marcia A. Wheeler		Yale University School of Medicine, New Haven, CT 06520				Bladder cancer detection with urinary survivin, an inhibitor of apoptosis	[Frontiers in Bioscience 7, e36-41, February 1, 2002]	11815300
Dario C. Altieri		Yale University School of Medicine, New Haven, CT 06520				Bladder cancer detection with urinary survivin, an inhibitor of apoptosis	[Frontiers in Bioscience 7, e36-41, February 1, 2002]	11815300
Robert M. Weiss		Yale University School of Medicine, New Haven, CT 06520	Robert.Weiss@yale.edu	203-785-2863	203-785-4043	Bladder cancer detection with urinary survivin, an inhibitor of apoptosis	[Frontiers in Bioscience 7, e36-41, February 1, 2002]	11815300
Maki Ujiie,		University of British Columbia, Vancouver, BC,V6T 1Z3				p97 as a biomarker for alzheimer disease	[Frontiers in Bioscience 7, e42-47, February 1, 2002]	11815303
Dara L. Dickstein		University of British Columbia, Vancouver, BC,V6T 1Z3				p97 as a biomarker for alzheimer disease	[Frontiers in Bioscience 7, e42-47, February 1, 2002]	11815303
Wilfred A. Jefferies		University of British Columbia, Vancouver, BC,V6T 1Z3	wilf@brc.ubc.ca	604-822-6961	604-822-7815	p97 as a biomarker for alzheimer disease	[Frontiers in Bioscience 7, e42-47, February 1, 2002]	11815303
Ali Ghadersohi		Roswell Park Cancer Institute, Buffalo, NY 14263				Tumor antigens and markers for breast and ovarian cancers	[Frontiers in Bioscience 7, e48-57, February 1, 2002]	11815284
Kasyapa Chitta		Roswell Park Cancer Institute, Buffalo, NY 14263				Tumor antigens and markers for breast and ovarian cancers	[Frontiers in Bioscience 7, e48-57, February 1, 2002]	11815284
William R. Greco		Roswell Park Cancer Institute, Buffalo, NY 14263				Tumor antigens and markers for breast and ovarian cancers	[Frontiers in Bioscience 7, e48-57, February 1, 2002]	11815284
Shashi Harvey		Roswell Park Cancer Institute, Buffalo, NY 14263				Tumor antigens and markers for breast and ovarian cancers	[Frontiers in Bioscience 7, e48-57, February 1, 2002]	11815284
Janet Winston		Roswell Park Cancer Institute, Buffalo, NY 14263				Tumor antigens and markers for breast and ovarian cancers	[Frontiers in Bioscience 7, e48-57, February 1, 2002]	11815284
Harry Slocum		Roswell Park Cancer Institute, Buffalo, NY 14263				Tumor antigens and markers for breast and ovarian cancers	[Frontiers in Bioscience 7, e48-57, February 1, 2002]	11815284
Kunle Odunsi		Roswell Park Cancer Institute, Buffalo, NY 14263				Tumor antigens and markers for breast and ovarian cancers	[Frontiers in Bioscience 7, e48-57, February 1, 2002]	11815284
Ashwani K. Sood		Roswell Park Cancer Institute, Buffalo, NY 14263	ashwani.sood@roswellpark.org	716-845-2395	716-845-7613	Tumor antigens and markers for breast and ovarian cancers	[Frontiers in Bioscience 7, e48-57, February 1, 2002]	11815284
Ethel Cesarman		Weill Medical College of Cornell University, New York, NY	ecesarm@med.cornell.edu	212-746-8838	212-746-4483	Epstein-Barr Virus (EBV) and lymphomagenesis	[Frontiers in Bioscience 7, e58-65, Feburary 1, 2002]	11815280
David L. Hahn		Dean Medical Center, Madison WI 53704,				Chlamydia pneumoniae as a respiratory pathogen	[Frontiers in Bioscience 7, e66-76, March 1, 2002]	11861211
Anthony A. Azenabor		University of Wisconsin Medical School, Madison. WI 53706				Chlamydia pneumoniae as a respiratory pathogen	[Frontiers in Bioscience 7, e66-76, March 1, 2002]	11861211
Wandy L. Beatty		University of Wisconsin Medical School, Madison. WI 53706				Chlamydia pneumoniae as a respiratory pathogen	[Frontiers in Bioscience 7, e66-76, March 1, 2002]	11861211
Gerald I. Byrne		University of Wisconsin Medical School, Madison. WI 53706	gibyrne@facstaff.wisc.edu .	608-263-2494	608-265-0683	Chlamydia pneumoniae as a respiratory pathogen	[Frontiers in Bioscience 7, e66-76, March 1, 2002]	11861211
Elizabeth A. Sisk		University of Michigan Medical School, Ann Arbor, MI 48109-0934.				Clinical implications of human papillomavirus infection	[Frontiers in Bioscience 7, e77-84, March 1, 2002]	11861218
Erle S. Robertson		University of Michigan Medical School, Ann Arbor, MI 48109-0934.	esrobert@umich.edu	734-647-7296	734-647-9647	Clinical implications of human papillomavirus infection	[Frontiers in Bioscience 7, e77-84, March 1, 2002]	11861218
Frederick Urbach		438 Clairemont Road, Villanova PA 19085 USA	DrFredU@aol.com	610-525-7440		The historical aspects of photocarcinogenesis	[Frontiers in Bioscience 7, e85-90, March 1, 2002]	11861223
Nasser Chegini		University of Florida, Gainesville, FL, 32610	cheginin@obgyn.ufl.edu	352-392-3929	352-392-6994	Peritoneal molecular environment, adhesion formation and clinical implication	[Frontiers in Bioscience 7, e91-115, April 1, 2002]	11897550
Douglas R. Johnston		Harvard Medical School, Boston, MA, 02114				Overcoming cardiac allograft vasculopathy (CAV) by inducing tolerance	[Frontiers in Bioscience 7, e116-128, May 1, 2002]	11991839
Mohamed H. Sayegh		Harvard Medical School, Boston, MA, 02114				Overcoming cardiac allograft vasculopathy (CAV) by inducing tolerance	[Frontiers in Bioscience 7, e116-128, May 1, 2002]	11991839
Joren C. Madsen		Harvard Medical School, Boston, MA, 02114	madsen@helix.mgh.harvard.edu	617-724-1130	617-724-8834	Overcoming cardiac allograft vasculopathy (CAV) by inducing tolerance	[Frontiers in Bioscience 7, e116-128, May 1, 2002]	11991839
Mahzuz Karim		John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK	mkarim@doctors.org.uk			The role of the graft in establishing tolerance	[Frontiers in Bioscience 7, e129-154, May 1, 2002]	11991840
Ulrich Steger		John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK				The role of the graft in establishing tolerance	[Frontiers in Bioscience 7, e129-154, May 1, 2002]	11991840
Andrew R. Bushell		John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK				The role of the graft in establishing tolerance	[Frontiers in Bioscience 7, e129-154, May 1, 2002]	11991840
Kathryn J. Wood		John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK	kathryn.wood@nds.ox.ac.uk	44-1865-221300	44-1865-763545	The role of the graft in establishing tolerance	[Frontiers in Bioscience 7, e129-154, May 1, 2002]	11991840
Elsdon Storey		Alfred Hospital Campus, Prahran, 3181, Australia	elsdon.storey@med.monash.edu.au	613-276 2552	613-9276 2458	Patterns of cognitive impairment in Alzheimer's disease: assessment and differential diagnosis	[Frontiers in Bioscience 7, e155-184, May 1, 2002]	11991855
Melissa J. Slavin		University of Melbourne, Parkville, 3052, Australia				Patterns of cognitive impairment in Alzheimer's disease: assessment and differential diagnosis	[Frontiers in Bioscience 7, e155-184, May 1, 2002]	11991855
Glynda J. Kinsella		La Trobe University, Bundoora, 3083, Australia				Patterns of cognitive impairment in Alzheimer's disease: assessment and differential diagnosis	[Frontiers in Bioscience 7, e155-184, May 1, 2002]	11991855
Robert E. Means		Harvard Medical School, 1 Pine Hill Drive Southborough, MA 01772	robert_means@hms.harvard.edu	508-624-8099	508-786-1416	Kaposi's sarcoma associated Herpesvirus immune evasion strategies	[Frontiers in Bioscience 7, e185-203, May 1, 2002]	11991843
Sabine M. Lang		Harvard Medical School, 1 Pine Hill Drive Southborough, MA 01772